TW200418865A - Production of iridium complexes - Google Patents
Production of iridium complexes Download PDFInfo
- Publication number
- TW200418865A TW200418865A TW92130189A TW92130189A TW200418865A TW 200418865 A TW200418865 A TW 200418865A TW 92130189 A TW92130189 A TW 92130189A TW 92130189 A TW92130189 A TW 92130189A TW 200418865 A TW200418865 A TW 200418865A
- Authority
- TW
- Taiwan
- Prior art keywords
- ring
- formula
- group
- compound
- optionally substituted
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 44
- 150000002503 iridium Chemical class 0.000 title description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 138
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims abstract description 101
- 229910052741 iridium Inorganic materials 0.000 claims abstract description 88
- -1 diene compound Chemical class 0.000 claims abstract description 83
- 238000006243 chemical reaction Methods 0.000 claims abstract description 66
- 238000000034 method Methods 0.000 claims abstract description 47
- 239000007858 starting material Substances 0.000 claims abstract description 16
- 125000005843 halogen group Chemical group 0.000 claims abstract description 14
- 125000001072 heteroaryl group Chemical group 0.000 claims description 51
- 125000003118 aryl group Chemical group 0.000 claims description 46
- 125000000217 alkyl group Chemical group 0.000 claims description 28
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 27
- 125000003107 substituted aryl group Chemical group 0.000 claims description 25
- 125000004432 carbon atom Chemical group C* 0.000 claims description 21
- 125000003545 alkoxy group Chemical group 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- 125000004429 atom Chemical group 0.000 claims description 10
- 125000004076 pyridyl group Chemical group 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 238000002955 isolation Methods 0.000 abstract description 10
- 238000000746 purification Methods 0.000 abstract description 10
- 150000002504 iridium compounds Chemical class 0.000 abstract description 2
- 238000005580 one pot reaction Methods 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 66
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 45
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 33
- 239000002904 solvent Substances 0.000 description 33
- 229910052757 nitrogen Inorganic materials 0.000 description 30
- 238000010992 reflux Methods 0.000 description 29
- 125000001424 substituent group Chemical group 0.000 description 29
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 22
- 229910052709 silver Inorganic materials 0.000 description 21
- 239000004332 silver Substances 0.000 description 21
- 239000000725 suspension Substances 0.000 description 21
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 18
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 18
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 239000003446 ligand Substances 0.000 description 17
- 125000001624 naphthyl group Chemical group 0.000 description 17
- 239000000843 powder Substances 0.000 description 16
- 125000001544 thienyl group Chemical group 0.000 description 16
- 229940093475 2-ethoxyethanol Drugs 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 15
- 239000011541 reaction mixture Substances 0.000 description 15
- 125000000304 alkynyl group Chemical group 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- YMWUJEATGCHHMB-DICFDUPASA-N dichloromethane-d2 Chemical compound [2H]C([2H])(Cl)Cl YMWUJEATGCHHMB-DICFDUPASA-N 0.000 description 13
- 239000003480 eluent Substances 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 125000002541 furyl group Chemical group 0.000 description 12
- 239000007789 gas Chemical group 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- 239000002585 base Substances 0.000 description 11
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 125000003342 alkenyl group Chemical group 0.000 description 10
- 238000005401 electroluminescence Methods 0.000 description 9
- 239000012299 nitrogen atmosphere Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 229910000029 sodium carbonate Inorganic materials 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- 235000005979 Citrus limon Nutrition 0.000 description 7
- 244000131522 Citrus pyriformis Species 0.000 description 7
- 239000012298 atmosphere Substances 0.000 description 7
- 239000000539 dimer Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 238000010898 silica gel chromatography Methods 0.000 description 7
- 125000004414 alkyl thio group Chemical group 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 125000003396 thiol group Chemical class [H]S* 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 125000002950 monocyclic group Chemical group 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 4
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 230000001443 photoexcitation Effects 0.000 description 4
- 125000003367 polycyclic group Chemical group 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 3
- TVRHDFJMHSSQCP-UHFFFAOYSA-M [Ir]Cl.C1CC=CCCC=C1 Chemical class [Ir]Cl.C1CC=CCCC=C1 TVRHDFJMHSSQCP-UHFFFAOYSA-M 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 238000011031 large-scale manufacturing process Methods 0.000 description 3
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DANYXEHCMQHDNX-UHFFFAOYSA-K trichloroiridium Chemical class Cl[Ir](Cl)Cl DANYXEHCMQHDNX-UHFFFAOYSA-K 0.000 description 3
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 3
- 229910052722 tritium Inorganic materials 0.000 description 3
- RRKODOZNUZCUBN-CCAGOZQPSA-N (1z,3z)-cycloocta-1,3-diene Chemical compound C1CC\C=C/C=C\C1 RRKODOZNUZCUBN-CCAGOZQPSA-N 0.000 description 2
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- OQLZINXFSUDMHM-UHFFFAOYSA-N Acetamidine Chemical compound CC(N)=N OQLZINXFSUDMHM-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000005361 D2 NMR spectroscopy Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 2
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 241001674048 Phthiraptera Species 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical compound C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 125000003963 dichloro group Chemical group Cl* 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 2
- 229940071536 silver acetate Drugs 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- CMLIMJTZVBNQCA-UHFFFAOYSA-N 1,2-diphenylbutane-1,3-dione Chemical compound C=1C=CC=CC=1C(C(=O)C)C(=O)C1=CC=CC=C1 CMLIMJTZVBNQCA-UHFFFAOYSA-N 0.000 description 1
- QTYUSOHYEPOHLV-FNORWQNLSA-N 1,3-Octadiene Chemical compound CCCC\C=C\C=C QTYUSOHYEPOHLV-FNORWQNLSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- JUQPJJFSZJPLPK-UHFFFAOYSA-N 1-butoxy-9h-fluorene Chemical compound C1C2=CC=CC=C2C2=C1C(OCCCC)=CC=C2 JUQPJJFSZJPLPK-UHFFFAOYSA-N 0.000 description 1
- BLXJAQAAGUYYLF-UHFFFAOYSA-N 1-phenoxy-9h-fluorene Chemical compound C=12CC3=CC=CC=C3C2=CC=CC=1OC1=CC=CC=C1 BLXJAQAAGUYYLF-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- FJPGAMCQJNLTJC-UHFFFAOYSA-N 2,3-Heptanedione Chemical compound CCCCC(=O)C(C)=O FJPGAMCQJNLTJC-UHFFFAOYSA-N 0.000 description 1
- 125000006507 2,4-difluorobenzyl group Chemical group [H]C1=C(F)C([H])=C(F)C(=C1[H])C([H])([H])* 0.000 description 1
- WLIIIDKWCWPADG-UHFFFAOYSA-N 2-(2,4-difluorophenyl)pyridine Chemical compound FC1=CC(F)=CC=C1C1=C[C]=CC=N1 WLIIIDKWCWPADG-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- RABQBOCUJIKPFY-UHFFFAOYSA-N 4-(9H-fluoren-1-yl)morpholine Chemical compound C1(=CC=CC=2C3=CC=CC=C3CC1=2)N1CCOCC1 RABQBOCUJIKPFY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WGOQTNXYTDSHRT-UHFFFAOYSA-N 9h-fluorene-1-carbonitrile Chemical compound C1C2=CC=CC=C2C2=C1C(C#N)=CC=C2 WGOQTNXYTDSHRT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- KLJIFBVBKMFTSR-UHFFFAOYSA-N CC(=O)C.C(C)(=N)N.[Ir+3] Chemical compound CC(=O)C.C(C)(=N)N.[Ir+3] KLJIFBVBKMFTSR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- YZGQDNOIGFBYKF-UHFFFAOYSA-N Ethoxyacetic acid Chemical compound CCOCC(O)=O YZGQDNOIGFBYKF-UHFFFAOYSA-N 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- KEJQJRKFXBISEI-UHFFFAOYSA-N [Ir+3].N(C(=O)C)CC(C)=O Chemical compound [Ir+3].N(C(=O)C)CC(C)=O KEJQJRKFXBISEI-UHFFFAOYSA-N 0.000 description 1
- DYROCUIGIIRTIX-UHFFFAOYSA-N [Ir+].C1=CCCC=CCC1 Chemical compound [Ir+].C1=CCCC=CCC1 DYROCUIGIIRTIX-UHFFFAOYSA-N 0.000 description 1
- UYVZCGGFTICJMW-UHFFFAOYSA-N [Ir].[Au] Chemical compound [Ir].[Au] UYVZCGGFTICJMW-UHFFFAOYSA-N 0.000 description 1
- KSZVHVUMUSIKTC-UHFFFAOYSA-N acetic acid;propan-2-one Chemical compound CC(C)=O.CC(O)=O KSZVHVUMUSIKTC-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 210000000877 corpus callosum Anatomy 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- XQRFBOZKKUDWIJ-UHFFFAOYSA-N difluoro(phenyl)sulfanium Chemical compound F[S+](F)c1ccccc1 XQRFBOZKKUDWIJ-UHFFFAOYSA-N 0.000 description 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- TZMFJUDUGYTVRY-UHFFFAOYSA-N ethyl methyl diketone Natural products CCC(=O)C(C)=O TZMFJUDUGYTVRY-UHFFFAOYSA-N 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid group Chemical group C(CCCCC)(=O)O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- MILUBEOXRNEUHS-UHFFFAOYSA-N iridium(3+) Chemical compound [Ir+3] MILUBEOXRNEUHS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- AJAZMOFONMJGNP-WMZOPIPTSA-N n-[(2s)-4-methyl-1-oxo-1-[[(2s)-3-oxo-4-(pyridin-2-ylsulfonylamino)butan-2-yl]amino]pentan-2-yl]-1-benzofuran-2-carboxamide Chemical compound O=C([C@H](C)NC(=O)[C@@H](NC(=O)C=1OC2=CC=CC=C2C=1)CC(C)C)CNS(=O)(=O)C1=CC=CC=N1 AJAZMOFONMJGNP-WMZOPIPTSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004706 n-propylthio group Chemical group C(CC)S* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical class CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 150000003281 rhenium Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- KZJPVUDYAMEDRM-UHFFFAOYSA-M silver;2,2,2-trifluoroacetate Chemical compound [Ag+].[O-]C(=O)C(F)(F)F KZJPVUDYAMEDRM-UHFFFAOYSA-M 0.000 description 1
- AYKOTYRPPUMHMT-UHFFFAOYSA-N silver;hydrate Chemical compound O.[Ag] AYKOTYRPPUMHMT-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- QMFYDAZWMAZXKO-UHFFFAOYSA-N sodium;pyridine Chemical compound [Na+].C1=CC=NC=C1 QMFYDAZWMAZXKO-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 150000003649 tritium Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical group [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0033—Iridium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Electroluminescent Light Sources (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
200418865 玫、發明說明 [發明所屬之技術領域] 本發明關於-種作為光激發元件等之材料之三 正·金屬化銥錯合物之製造方法。 [先前技術] 因為旎在較低電壓下激發高亮光使得有機電激發光 (d==mineseenee; EL)元件在實際使用作為包括超薄顯 不裔,電子紙張之下一世代之顯示器元件的觀點上受到注 目〇 ;EL元件具有咼於液晶之反應速度以及同步激 可藉由使用有機EL元件形成薄平面顯示器而無液 —月光It形。有機EL元件係使用與發光二極體(LED) 相同基準t EL發光元件,其特徵為使用有機螢光物質作 發光物質。 已開發多種用於有機EL元件之發光材料,特別是例 如雙(2-苯基D比錠基錶乙醯基丙 酮鹽(下文以化合物3]稱之)與參(2•苯基吡錠基以丨2,)銥 (下文以化合物5-1稱之)之三價六芽正-金屬化銥錯合物受 到注目,理由為其有較高於螢光發光量子效率之特徵而可 由三態激發態激發磷光,而且其光輻射波長視需要地可藉 由改變配位體化學結構而調整。例如,如討論於下之使用 化合物5-1之光-激發元件用於綠光發光之外部量子效率中 有9%南之值(蒼見非專利文件ip雙[2_(2,·笨并噻吩基) 吡錠基銥(III)乙醯基丙酮鹽(下文以化合物3丨稱之) 315064 200418865 :報導為具有非常高量子效率與顏色純度之紅色填光-激 舍材料(參見非專利文獻2)。由前 — )由則述事實可知,周邊元件設 计/、錯合物合成之有效方法办 之研九正活躍地進行且將有助 方;其貫際使用。 在三價六芽正_金屬化銥錯合物之製法上,已報導有種 =法。例如’在高溫下銀鹽與水的存在中,將氯化峰工) 水“勿與大量配位體反應之製造方法(參見近年示例之專 >利文件υ。根據該製法,所獲得之目標產物的 至 82% 〇 如另-近例,已知在高溫下甘油中,將銀(πι)乙酿基 丙酮鹽與理論值量之配位體反應之製法(專利文件2),其中 2之產率為75%。雖然產率為中等,但製法需要嚴格的 ^應條件,而且該製法無法將不同種類之㈣體導入鉉化 。物(例如,式(V)之錯合物)。 在改進該步驟中,有報導根據所謂的N〇n〇y_a步驟 (茶見非專利文件3)將氯化銀(叫水合物與理論值量之配 位體反應而合成式(Π)之三價六芽正、金屬化銀二核錯合 物’接著在驗存在下鱼乙g夜其& 你双什牡卜,、6 I基丙酮鹽反應而得乙醯基丙酮 鹽錯合物’而後在高溫下甘油中與理論值量之配位體反應 而得式00之三價六芽正-金屬化銀錯合物(參見非專利文 件4與5及近年示例之專利文件3)。在此步驟中,第一步 驟之報導糊75%或更高,第二步驟為75至9〇%,而 第三步驟為85%或更高(參見非專利文件5)。根據此步驟, 含有不同配位體之錯合物(式⑼))與含有相同配位體之錯 315064 6 200418865 合物(式(v))可由相同起始物而分別製造且有好產率。然而 其中有些問題,反應必須在多個步驟進行而且個別的中間 體與目標化合物需要複雜的單離與純化步驟,此將引起目 標化合物之彳貝失。 (參考文件) 專利文件1 : WO 02/02714 專利文件2 : WO 02/15645 專利文件 3 : JP-A No.1 05055 非專利文件 i ·· Bald0 M. A. et al·,APP丨· Phys· Lett., 1999, 75, 4-6 非專利文件 2: Adachi,C. et al·,Appl phys _ , 2001,78, 1622-1624 非專利文件 3 : M. N_yama,Bull. chem. Soc. Jpn., 1974, 47(3),767-768 非專利文件 4 : S· Lamansky,et al” J· Am· Chem. Soc·, 2001, 123, 4304-4312 非專利文件 5: S· Lamansky,et al” Inorg. Chem,2〇〇1, 40, 1704-1711 [發明内容]200418865 Rose, description of the invention [Technical field to which the invention belongs] The present invention relates to a method for manufacturing an ortho-metalized iridium complex as a material of a photoexcitation element. [Prior art] Because tritium excites high-brightness light at a lower voltage, organic electro-excitation light (d == mineseenee; EL) elements are practically used as a display element that includes ultra-thin display and electronic paper under one generation. Attention has been paid to the EL element. The EL element has a response speed of liquid crystal and synchronous excitation. It can form a thin flat display by using an organic EL element without a liquid-moonlight It shape. The organic EL element uses the same reference EL light emitting element as a light emitting diode (LED), and is characterized by using an organic fluorescent substance as a light emitting substance. A variety of light-emitting materials for organic EL elements have been developed, in particular, for example, bis (2-phenyl D than indium based epiethylacetone acetone salt (hereinafter referred to as compound 3)) and ginseng (2 • phenylpyridinyl The trivalent hexabud n-metallized iridium complexes with 丨 2,) iridium (hereinafter referred to as compound 5-1) have attracted attention because of their higher quantum efficiency than fluorescent luminescence and can be changed into three states. The excited state excites phosphorescence, and its light radiation wavelength can be adjusted by changing the chemical structure of the ligand as needed. For example, as discussed below, the light-excitation element of compound 5-1 is used for the external quantum of green light emission 9% of the value of the South (Cang Jian non-patent document ip bis [2_ (2, · benzythienyl) pyridinium iridium (III) acetamidoacetone salt (hereinafter referred to as compound 3 丨) 315064 200418865 : Reported as a red light-filled-excitation material with very high quantum efficiency and color purity (see Non-Patent Document 2). From the previous-), it can be seen from the facts that effective methods for peripheral element design and complex compound synthesis The Office of the Research Institute is being actively carried out and will help the party; its consistent use. In the production method of valence six buds _ metallized iridium complexes, there have been reported a number of methods. For example, 'the peak of chlorination in the presence of silver salt and water at high temperature) water "Do not react with a large number of ligands The manufacturing method (see the example of the recent years of the patent document). According to this manufacturing method, up to 82% of the target product obtained. As in other recent examples, it is known that silver (πι) is brewed in glycerol at high temperature. A method for reacting acetylacetonate with a theoretical amount of ligand (Patent Document 2), wherein the yield of 2 is 75%. Although the yield is medium, the method requires strict reaction conditions, and the method cannot be different Kinds of corpus callosum are introduced into compounds. For example (complex of formula (V)). In the improvement of this step, it is reported that the chlorination is performed according to the so-called Nonya step (see Non-Patent Document 3 for tea). Silver (called a hydrate reacted with a theoretical amount of a ligand to synthesize a trivalent six bud normal, metallized silver dinuclear complex of formula (Π) ', and then in the presence of the fish, it ’s & you Shuangshi The reaction of 6 I-based acetone salt to obtain acetamyl acetone salt complex, and then the theoretical value in glycerol at high temperature The amount of the ligand is reacted to obtain the trivalent hexabud n-metal silver complex of formula 00 (see Non-Patent Documents 4 and 5 and Patent Document 3 of Examples in Recent Years). In this step, the first step is reported The paste is 75% or higher, the second step is 75 to 90%, and the third step is 85% or higher (see Non-Patent Document 5). According to this step, a complex containing different ligands (formula Ii)) The same compound containing the same ligand as 315064 6 200418865 (formula (v)) can be produced separately from the same starting material with good yield. However, there are some problems in that the reaction must be performed in multiple steps and individually Complex intermediates and target compounds require complex isolation and purification steps, which will cause loss of target compounds. (Reference Documents) Patent Document 1: WO 02/02714 Patent Document 2: WO 02/15645 Patent Document 3: JP-A No. 1 05055 Non-Patent Document i ·· Bald0 MA et al ·, APP 丨 · Phys · Lett. , 1999, 75, 4-6 Non-Patent Document 2: Adachi, C. et al., Appl phys _, 2001, 78, 1622-1624 Non-Patent Document 3: M. N_yama, Bull. Chem. Soc. Jpn., 1974, 47 (3), 767-768 Non-Patent Document 4: S. Lamansky, et al ”J. Am. Chem. Soc., 2001, 123, 4304-4312 Non-Patent Document 5: S. Lamansky, et al” Inorg. Chem, 2001, 40, 1704-1711 [Summary of the Invention]
Mb N … L二價六芽正-金屬化銀錯合物作為有機電激發 光(EL)元件之光激發材料。然而其產生方法,必須經由複 1 ’因此期望建立更便利的步驟用於產生高產該 ° 而有助於作為光激發材料之該錯合物之實際使 315064 7 200418865 用0 本發明之目的在於_德制、iL A 1 、徒ί、 種衣k作為光激發元件材料 價六芽正-金屬化銥錯合物之便利與有效之方法。 之 (II)所示之三價六芽正_金屬化銥二核錯合物 本發明人致力於研究而開發一種有效且便利的製造方 法用於在溫和條件中產生三價六芽正_金屬化銥二核錯合 物。結果發現在溫和的條件下使用式⑴所示之單價錶二核 錯合物作為起始物進行反應會在短時間内得到有效量之式Mb N… L divalent hexabud n-silver metal complexes are used as photoexcitation materials for organic electroluminescence (EL) devices. However, its production method must be complexed by 1 '. Therefore, it is expected to establish more convenient steps for producing high yields of this °, which will help the actual use of the complex as a photoexcitation material. 315064 7 200418865 The purpose of the present invention is _ Convenient and effective method for valence six-bud n-metallized iridium complex of German-made, iL A 1, Tu L, seed coat k as the material of the photo-excitation element. The trivalent hexabud ortho_metallized iridium dinuclear complex shown in (II) The present inventors have devoted research to develop an effective and convenient manufacturing method for producing trivalent hexabud ortho_metal in mild conditions Iridium dinuclear complex. As a result, it was found that under mild conditions, the reaction using the monovalent bi-nuclear complex shown in formula (i) as the starting material will give an effective amount of formula in a short time.
在單離與純化後,產生於此步驟之式⑼之錯合物可應 用於其他錯合物之合成。本發明人進一步致力於建立產生 錶錯合物之商業可應用步驟之研究’而結果發現產生於此 反應之式(II)之三價六芽正_金屬化銥二核錯合物在不需自 反應混合物中單離與純化下,可與置於相同反應槽之式 (VII)或(vm)化合物與鹼或式(VI)化合物與銀鹽反應,而在 高產率便利的方法中得到各個配位體相同之錯合物(式 i與配㈣不同之錯合物(式(m)與(IV))’其中個別產物視需 要地可分開產生。因此,基於前述發現而完成本發明。 因此,本發明提供一種以銥化合物與配位化合物作為 起始物之三價六芽正_金屬化銥錯合物之製造方法,苴特徵 為使用由下式⑴所示之單價鉉二核錯合物作為原始銥二 合物: 315064 8 200418865After isolation and purification, the complex of formula IX produced in this step can be applied to the synthesis of other complexes. The present inventors have further devoted themselves to the study of establishing commercially applicable steps for generating epicomplexes, and as a result, have found that the trivalent hexabud n-metallized iridium dinuclear complexes of formula (II) resulting from this reaction are not required With isolation and purification from the reaction mixture, it can be reacted with a compound of formula (VII) or (vm) and a base or a compound of formula (VI) and a silver salt in the same reaction tank, and each can be obtained in a convenient and high yield method. The complex with the same ligand (formula i and a complex with different complexes (formulas (m) and (IV)) 'may be produced separately as needed. Therefore, the present invention has been completed based on the foregoing findings. Therefore, the present invention provides a method for producing a trivalent hexabud ortho-metallized iridium complex with an iridium compound and a coordination compound as starting materials, which is characterized by using a monovalent 铉 dinuclear error represented by the following formula ⑴ As the original iridium di-complex: 315064 8 200418865
(其中’A表非共軛二稀化合物;及X表齒素原子)。 更具體而言,本發明提供—種式㈤所示之三價六 -金屬化銥二核錯合物之製造方法:(Wherein 'A represents a non-conjugated dilute compound; and X represents a tooth element atom). More specifically, the present invention provides a method for manufacturing a trivalent hexa-metallized iridium dinuclear complex shown by formula ㈤:
(U) (其中環、^表視需要經取代之芳基或雜芳基;環c 要經取代之含氮芳基;環B與環c可彼此形成稠合環; 定義如前述),其特微幺肢斗、 才效為將式(I)之單價銥二核錯合 (VI)化合物反應: ^(U) (where ring and ^ are optionally substituted aryl or heteroaryl groups; ring c is a nitrogen-containing aryl group to be substituted; ring B and ring c may form a fused ring with each other; as defined above), which Special micro-limb fighting, the effect is to react the monovalent iridium dinuclear complex (VI) compound of formula (I): ^
(VI) (其中環B與環c定義如前述) 本舍明之製造方〉去可簡略地由T列反應式表示。 式⑴+式(VI)〜式(„) 本毛月也提(、種將產生於前述步驟之式(Π)錯合物 轉成式(III)、(IV)或(V)所示之三價六芽正—金屬化銀錯合物 之方法。在此反應中,式(π)錯合物不需自反應混合物中單 9 315064 離與純化下,使用作為下_ 為本發明之另—主要特徵。 簡明而言,本發明提供 金屬化銥錯合物之製造方每 步驟之完整的反應混合物。此 一種式(III)所示之三價六芽正-(VI) (wherein the ring B and the ring c are defined as described above) The manufacturer of the present invention can be simply expressed by the reaction formula of column T. Formula ⑴ + Formula (VI) ~ Formula („) This Maoyue also mentioned (, the species will be the complex of formula (Π) generated in the previous step into the formula (III), (IV) or (V) Trivalent six bud normal-metal silver complex method. In this reaction, the complex of formula (π) does not need to be separated and purified from the reaction mixture. —Main features. Briefly, the present invention provides a complete reaction mixture for each step in the manufacture of a metalized iridium complex. This is a trivalent hexabud that is represented by formula (III):
J =與11各自獨立地表烷基、烷氧基、芳基或雜芳基; 。 氯原子燒基、芳基或雜芳基;與R2或R2與R3 鄰之碳原子一起形成環;環B與環C定義如前述) j、寸社在夂將式⑴之單價銥二核錯合物與式(VI)化合物反 义而侍式(II)化合物,接著將式化合物與式(vII)化合物 反應:J = each independently of 11 is alkyl, alkoxy, aryl or heteroaryl; A chlorine atom, an aryl group, or a heteroaryl group; together with the carbon atom adjacent to R2 or R2 and R3, a ring is formed; the definition of ring B and ring C is as described above. The compound is antisense to a compound of formula (VI) while waiting for a compound of formula (II), and then reacting a compound of formula with a compound of formula (vII):
(VII) (其中R】、R2與R3定義如前述)。 本發明之製造方法可簡明地以下列反應式表示。 第一步:式(I) + 式(VI)-►式(II) 第二步··式(II) +式——►式(III) 本發明之製造方法可逐步或連續地進行。當連續地進 行反應時,反應可藉由將式(VII)化合物添加至第一步之反 應混合物中而在相同反應槽中進行,亦即,單槽反應。 10 315064 200418865 屬化::=t:種式(IV)所示之三價六芽正-金(VII) (wherein R], R2 and R3 are as defined above). The production method of the present invention can be expressed simply by the following reaction formula. Step 1: Formula (I) + Formula (VI)-► Formula (II) Step 2 · Formula (II) + Formula-► Formula (III) The manufacturing method of the present invention can be performed stepwise or continuously. When the reaction is performed continuously, the reaction can be performed in the same reaction tank by adding the compound of the formula (VII) to the reaction mixture in the first step, that is, a single tank reaction. 10 315064 200418865 genus :: = t: trivalent six buds as shown in formula (IV)
(IV) (/、中ί衣B與% c定義如前述,而環D表視需要經取代之 吡啶基。此外,環B舆環c可彼此形成稠合環) 其特徵為將式⑴之單價銥二核錯合物與式(VI)化合物反應 而接著與式(VIII)化合物反應:(IV) (/, Zhong B and% c are as defined above, and ring D represents a substituted pyridyl group as required. In addition, ring B and ring c may form a condensed ring with each other) It is characterized by the following formula: The monovalent iridium dinuclear complex is reacted with a compound of formula (VI) and then with a compound of formula (VIII):
(其中環D定義如前述) 本發明之製造方法可簡明地以下列反應式表示。 第一步:式(I) + 式(VI)-►式(II) 第二步:式(II) + 式(VIII) —►式(IV) 本發明之製造方法可逐步或連續地進行。當連續地進 行反應時,反應可藉由將式(VIII)化合物添加至第_步之 反應混合物中而在相同反應槽中進行,亦即,單槽反鹿。 此外,本發明也提供/種式(V)所示之三價六芽正·金 屬化銥錯合物之製造方法: 315064 11(Wherein ring D is as defined above) The production method of the present invention can be expressed simply by the following reaction formula. Step 1: Formula (I) + Formula (VI)-► Formula (II) Step 2: Formula (II) + Formula (VIII)-► Formula (IV) The manufacturing method of the present invention can be performed stepwise or continuously. When the reaction is performed continuously, the reaction can be performed in the same reaction tank by adding the compound of the formula (VIII) to the reaction mixture in the step _, that is, a single tank reverse deer. In addition, the present invention also provides / manufacturing method of trivalent six bud n-metal iridium complex shown by formula (V): 315064 11
(V) (二二環^與環C定義如前述)(V) (Di-bicyclo ^ and ring C are as defined above)
'、彳政為將式⑴之單價銥二核錯合物與式(VI)化合物反 |應,以產 + 4 ,TT、i A r % 化合物,接著與銀鹽及式(VI)化合物反 心 ^本t明之製造方法可簡明地以下列反應式表示。 = 步.式(1) +式(VI)——►式(II) 第=步:式(π) +銀鹽+式(VI) —κ 式(V) "t月之製造方法可逐步或連續地進行。當連續地進 :反應蚪’反應可藉由將銀鹽添加至第-步之反應混合物 而在相同反應槽中進行,亦即,單槽反應。', Zheng Zheng reacts the monovalent iridium dinuclear complex of formula ⑴ with a compound of formula (VI) to produce + 4, TT, i A r% compound, and then reacts with the silver salt and compound of formula (VI) The manufacturing method of this method can be expressed simply by the following reaction formula. = Step. Formula (1) + Formula (VI) —— ►Formula (II) Step = Step: Formula (π) + Silver Salt + Formula (VI) —κ Formula (V) " t month manufacturing method can be gradually Or continuously. When continuously proceeding: the reaction 蚪 'reaction can be performed in the same reaction tank by adding a silver salt to the reaction mixture in the first step, that is, a single tank reaction.
本發明之三僧丄玆γ A P 、/、g正-孟屬化銀錯合物之製Preparation of three monks of the present invention γ A P, /, g n-Meng silver complex
_特徵為使用式⑴所干夕輩押Μ I 斤不之早仏銥二核錯合物作為起始物。 發明之製造方法,其特徵也 牧a a 之二如、六牙正〜金屈 銥錯合物可使用式(I)所示之單價贫—仿辑八 <早如、銥一核錯合物作為起_Characterized by the use of the formula 干 夕 イ Μ イ I 不 イ 之 不 iridium dinuclear complex as a starting material. The manufacturing method of the invention is also characterized by the unitary aa bis, six teeth, and gold iridium complex, which can use the monovalent depleted-imitation series VIII < as early as, iridium mononuclear complex As
物而在相同反應槽中產生, .^ ^ U 王亦即,早槽反應。根據本癸昍 之製造方法,可產生含有多婵 ^月 生a有夕樣配位化合物作為配位 錯合物’例如產生下戎^ 銀 玍下式(Π)、式(111)、式(1 之三價六芽銥錯合物·· 飞(v)所示 3Ϊ5064 12 200418865The product is produced in the same reaction tank,. ^ ^ U Wang, that is, the early tank reaction. According to the production method of the present decanonium, it is possible to produce a complex compound containing a polypyridine a complex as an coordination complex, for example, to generate a silver compound, such as the following formula (Π), formula (111), formula ( 1 trivalent hexabud iridium complex ·· shown in (v) 3Ϊ5064 12 200418865
(V)(V)
(其中環B表視需要經取代之芳基或雜芳基;環C表視需 要經取代之含氮芳基;環D表視需要經取代之吡啶基;環 B與環C可彼此形成稠合環;X表鹵素原子;R1與R3各自 獨立地表烷基、烷氧基、芳基或雜芳基;R2表氫原子、烷 基、芳基或雜芳基;及R]與R2或R2與R3可與相鄰之碳 原子一起形成環)。 [實施方式] 13 315064 200418865 下面首先將解說作為本發明之製造方法之起始化合物 之式(I)所示之單價銥二核錯合物。 " 式⑴中* A所不之非-共軛二烯化合物可為環狀或 :被狀而且只要無負面效果情形了,可有-個或多個取代 :”:狀二稀化合物包括單環、多環、縮合環、與交聯環 壬一種。由A所示之較佳非-共軛二烯化合物包括,例 ’有5至20個碳原子’較佳為5至10個碳原子,特 :佳為環狀非-共軛二稀化合物。較佳之非_共軛二烯化合 之具體示例包括例如!,5_環辛二烯(c〇d)與雙環[m]庚 5-二烯(nbd)之環狀化合物。 在式⑴中由X所示之齒素原子包括,例如,氟原子 =、;;原子、與蛾原子,較佳為氯原子。式⑴之較隹 貝 核錯合物可由下式(IX)或(X)示之: X. '、.d (IX)(Where ring B represents an optionally substituted aryl or heteroaryl group; ring C represents an optionally substituted nitrogen-containing aryl group; ring D represents an optionally substituted pyridyl group; ring B and ring C may form a thick Rings; X represents a halogen atom; R1 and R3 each independently represent an alkyl, alkoxy, aryl, or heteroaryl; R2 represents a hydrogen atom, alkyl, aryl, or heteroaryl; and R] and R2 or R2 And R3 can form a ring together with adjacent carbon atoms). [Embodiment] 13 315064 200418865 First, the monovalent iridium dinuclear complex represented by formula (I), which is the starting compound of the production method of the present invention, will be explained below. " The non-conjugated diene compound of formula A in formula A may be cyclic or: bedding and as long as there is no negative effect, there may be one or more substitutions: ": like dilute compounds include mono Ring, polycyclic, condensed ring, and crosslinked cyclonon. Preferred non-conjugated diene compounds shown by A include, for example, 'has 5 to 20 carbon atoms', preferably 5 to 10 carbon atoms. Special: It is preferably a cyclic non-conjugated dilute compound. Specific examples of preferred non-conjugated diene compounds include, for example, 5_cyclooctadiene (cod) and bicyclic [m] heptene 5- A cyclic compound of a diene (nbd). The halo atom represented by X in formula ⑴ includes, for example, a fluorine atom =, ;; atom, and a moth atom, preferably a chlorine atom. The nuclear complex can be represented by the following formula (IX) or (X): X. ', .d (IX)
(X) (其中X定義如前述)。 六# Τ δ H兄在本發明中產生之式(II)至(V)所示之三严 /、牙正-金屬化銥錯合物。 貝 在式(11)中,由環Β % 一 A、 芳基包括芳基、緩取代之一:需要經取代之芳基或雜 _ 之方基、雜芳基與經取代之雜芳其 芳基可舉示例為呈古 ^ 幻為"有6至14個碳原子之單環、多環或 14 315064 200418865 縮合環芳基。芳基之具體例包括苯基、萘基、蒽基等。 雜芳基可舉示例為例如具有丨至3個氮原子、氧原子 或硫原子作為雜原子之5_或6_員單環 '多環或縮合環 芳香族雜環基。雜芳基之具體例包括吡啶基、咪唑基、噻 唑基、呋喃基、苯并呋喃基、噻吩基、苯并嚷吩基等。 經取代之芳基包括前述之芳基而其中至少一個氫原子 為取代基所取代。經取代之”基包括前述之雜芳基而其 中至少一個氫原子為取代基所取代。 八 在該等基團之取代基包括烷基、烯基、炔基、芳基、 亦隹芳基烷氧基、院硫基、氰基、酸基、烷氧幾基、硝基、 鹵素原子、伸院二氧基(alkylenediGxy)等。烧基可為直鍵 或歧鏈或%狀烷基,而有例如i至丨5個碳原子,較佳為1 至6個碳原子。烧基之具體例包括甲基、乙基、正丙基、 2-丙基、正丁基、2_丁基、異丁基、第三丁基、正戍基、 2- 戊基、第三戊基、2_曱基丁基、3_曱基丁基、2,2·二甲基 丙基、正己基、2·己基、3_己基、第三已基、2_己基戊基: 3- 曱基戊基、4_曱基戊基、2_甲基戊基、環丙基、環丁 基、%戊基、環己基等。烯基可為直鏈或歧鏈烯基,而有 例如2至6個碳原子。烯基之具體例包括乙烯基、丙烯基、 1 丁烯基、2-丁烯基、戊烯基、己烯基等。炔基可為直鏈 或歧鏈炔基,而有例如2至5個碳原子。炔基之具體例包 括乙炔基、K丙炔基、3_丙炔基、丨_丁炔基、3_丁炔基、戊 炔基等。芳基可為直鏈或歧鏈芳基而有例如6至丨4個碳原 子之單環、多環或縮合環芳基。芳基之具體例包括笨基、 315064 200418865 萘基、蒽基等。雜芳基可為直鏈或歧鏈雜芳基而含有}至 j個例如氮原子、氧原子、硫原子等雜原子之5_或6_員單 %、多锿或縮合%芳香族雜環基,具體而言為吡啶基、咪 唑基、噻唑基、呋喃基、苯并呋喃基、噻吩基、苯并噻吩 基等。 烷氧基可為有例如1至6個碳原子之直鏈或歧 基。院氧基之具體例包括甲氧基、乙氧基、正丙氧基、2_ 丙氧基、正丁氧基、第二丁氧基、第三丁氧基、戊氧基、 己氧基等1硫基可為有例如U 6個碳原子之直鍵或歧 鏈烷硫基。烷硫基之具體例包括甲硫基、乙硫基、正丙硫 ^、2-丙硫基、正丁硫基、第二丁硫基、第三丁硫基、戊 硫基、己硫基等。酿基可為直鏈或歧鏈或環狀酿基,例如 衍生自…個碳原子之叛基之酿基。醒基之具體例包括 甲《:乙酸基、丙酿基、丁醒基、戍醒基、己酸基、苯 甲I基寺。烷氧羰基包括有例如2至7個碳原子之 歧鏈烷氧羰基。烷氧辦某呈雜 直鍵或 玩虱Μ基之具肢例包括曱氧羰 基、丙氧絲、正丁氧幾基、第三丁氧幾基、 ^ 0素原子包括’例如’氟原子、氯原子、溴 ”、舁碘原子。伸烷二氧基包括例如有Ί至3個 者’具體而言’例如’伸曱烷二氧基 : 丙烷二氧基等。 甲乙烷一乳基、伸 雜原芳基意指環中含有至少-個氮原子作為 …Π 可進一步含有1或2個例如氮原子、氧 原子或^子之雜料,包括5_或6_ ^ ^ 夕裱或縮合 315064 16 二W雜環基’丨中至少—個氮員子係與銥原子配位。 含虱芳其6 Λ ,,, 土匕括,例如,吡啶基、喹啉基等。 環C中八气 * 、 之^虱方基可經取代,而經取代之含氮芳基包 二基團中至少—個氫原子為取代基取代。取代基之示 歹’與裱Β中經取代之芳基與雜芳基相同。(X) (where X is as defined above). Six # TδδH is produced in the present invention by the three stern /, ortho-metalized iridium complexes shown by formulas (II) to (V). In formula (11), the ring B% -A, the aryl group includes one of the aryl group, and the slow substitution: a substituted aryl group or a hetero-square group, a heteroaryl group, and a substituted heteroaryl group. Exemplary radicals are exemplified as "monocyclic", "monocyclic, polycyclic" having 6 to 14 carbon atoms, or 14 315064 200418865 condensed ring aryl. Specific examples of the aryl group include phenyl, naphthyl, and anthracenyl. The heteroaryl group may be exemplified by a 5- or 6-membered monocyclic 'polycyclic or condensed ring aromatic heterocyclic group having 1 to 3 nitrogen atoms, oxygen atoms, or sulfur atoms as heteroatoms. Specific examples of heteroaryl include pyridyl, imidazolyl, thiazolyl, furyl, benzofuranyl, thienyl, benzofluorenyl, and the like. The substituted aryl group includes the aforementioned aryl group and at least one hydrogen atom thereof is substituted with a substituent. "Substituted" groups include the aforementioned heteroaryl groups and at least one of the hydrogen atoms is replaced by a substituent. Eight substituents in these groups include alkyl, alkenyl, alkynyl, aryl, and arylalkanes Oxy, thio, cyano, acid, alkoxy, nitro, halogen, alkylenediGxy, etc. The alkyl group can be a straight bond or a branched or% -like alkyl group, and There are, for example, i to 5 carbon atoms, preferably 1 to 6 carbon atoms. Specific examples of the alkyl group include methyl, ethyl, n-propyl, 2-propyl, n-butyl, 2-butyl, Isobutyl, third butyl, n-fluorenyl, 2-pentyl, third pentyl, 2-fluorenylbutyl, 3-fluorenylbutyl, 2,2-dimethylpropyl, n-hexyl, 2. Hexyl, 3-hexyl, third hexyl, 2-hexylpentyl: 3-fluorenylpentyl, 4-fluorenylpentyl, 2-methylpentyl, cyclopropyl, cyclobutyl,% pentyl Group, cyclohexyl group, etc. The alkenyl group may be a straight chain or a branched alkenyl group, and has, for example, 2 to 6 carbon atoms. Specific examples of the alkenyl group include a vinyl group, a propenyl group, a 1-butenyl group, and a 2-butenyl group. , Pentenyl, hexenyl, etc. The alkynyl can be straight chain or ammonium The alkynyl group has, for example, 2 to 5 carbon atoms. Specific examples of the alkynyl group include an ethynyl group, a K propynyl group, a 3-propynyl group, a butyrynyl group, a 3-butynyl group, a pentynyl group, and the like. The aryl group may be a linear or branched aryl group having, for example, a monocyclic, polycyclic, or condensed ring aryl group having 6 to 4 carbon atoms. Specific examples of the aryl group include a benzyl group, 315064 200418865 naphthyl group, anthracenyl group, etc. Heteroaryl may be a straight-chain or bi-chain heteroaryl containing 5 to 6 member members, such as nitrogen, oxygen, sulfur, and other heteroatoms. The cyclic group is specifically a pyridyl group, an imidazolyl group, a thiazolyl group, a furyl group, a benzofuryl group, a thienyl group, a benzothienyl group, etc. The alkoxy group may be a straight chain having 1 to 6 carbon atoms or Specific examples of oxy groups include methoxy, ethoxy, n-propoxy, 2-propoxy, n-butoxy, second butoxy, third butoxy, pentyloxy, and hexane. The 1thio group such as an oxy group may be a straight bond or a branched alkylthio group having 6 carbon atoms such as U. Specific examples of the alkylthio group include a methylthio group, an ethylthio group, an n-propylthio group, and a 2-propylthio group. , N-butylthio, Dibutylthio, tertiary butylthio, pentylthio, hexylthio, etc. The alkynyl group can be a straight or branched chain or a cyclic alkynyl group, such as a derivatyl group derived from a carbon atom of ... carbon atoms. Specific examples of the group include methyl group: acetate group, propyl group, butyl group, sulfonyl group, hexanoic acid group, and benzoyl group. The alkoxycarbonyl group includes, for example, a branched alkoxycarbonyl group having 2 to 7 carbon atoms. Some examples of alkoxy groups that are hetero-straight bonds or M-groups include fluorenyloxycarbonyl, propoxyl, n-butoxyquinyl, tertiary butoxyquinyl, ^ 0 atomic atoms including 'for example' fluorine atoms, Chlorine, bromine, and iodine. The butanedioxy group includes, for example, three to three, and specifically, for example, an butanedioxy group: propanedioxy group, and the like. Methylethane, lactyl, or heteroaryl means that the ring contains at least one nitrogen atom as ... II may further contain 1 or 2 impurities such as nitrogen atom, oxygen atom or ^, including 5_ or 6_ ^ ^ Even framed or condensed 315064 16 At least one nitrogen member of the two-W heterocyclyl group is coordinated with an iridium atom. Lice fragrant containing 6 Λ ,,, earth, for example, pyridyl, quinolyl and the like. The octyl group in ring C may be substituted, and at least one hydrogen atom in the substituted nitrogen-containing aryl group may be substituted by a substituent. The substituents 歹 'are the same as the substituted aryl and heteroaryl groups in Frame B.
玉TO ^衣與% c可結合形成環,包括例如苯并喹啉之稠合 環0 本發明之方法所產生之式(II)之三 銥錯合物之較佳例包括由下式(XI)所示者Jade TO ^ and% c can be combined to form a ring, including, for example, a fused ring of benzoquinoline. 0 Preferred examples of the triiridium complex of formula (II) produced by the method of the present invention include the following formula (XI As shown
R: 烯基、炔基、芳基、 、與Rn各自獨立地表氫原子、烷基、 (其中R8、R! 雜芳基、烷氧基、烷硫基、氰基、醯 :k氧板基、硝基、或齒素原子;χ表齒素原子;環B 義引述,% Β可與結合至環Β之吡啶環形成環)。 j (XI)中由R、R9、R]0與Rll所示之烧基、稀基、快 :务基纟元氧基、烧硫基、酸基與烧氧戴基可 有力成取代基或夕個取代基,其可舉示例如前述於式⑼ 之經取代之芳基或雜芳基者。在式(XI)中由X所示之鹵素 原子也與前述相同。 較佳之環Β包括笨基 、經取代之苯基、萘基、經取代 315064 200418865 之萘基、呋喃基、經取代之呋喃基、苯并呋喃基、經取代 之苯并咲喃基、噻吩基、經取代之噻吩基、苯并噻吩基、 經取代之苯并噻吩基等。在經取代之苯基、經取代之萘基、 經取代之咲喃基、經取代之苯并咲喃基、經取代之噻吩基、 與取代之苯并噻吩基上之取代基之示例為在式(II)中經取 代之芳基或雜芳基所提及者。 式(II)所示之三價六芽正-金屬化銥錯合物之具體例包 括下列化合物(Π-i)至(Π-xvi)。R: alkenyl, alkynyl, aryl, and Rn each independently represent a hydrogen atom, an alkyl group, (wherein R8, R! Heteroaryl, alkoxy, alkylthio, cyano, fluorene: k-oxylate , Nitro, or dentin atom; χ epidentin atom; meaning of ring B,% Β can form a ring with a pyridine ring bound to ring B). The alkynyl, dilute, and fast radicals represented by R, R9, R] 0, and R11 in j (XI) can effectively form substituents or thiol, thiol, acid, and alkynyl. As the substituents, there may be exemplified the substituted aryl or heteroaryl groups as described in the formula (I). The halogen atom represented by X in the formula (XI) is also the same as described above. Preferred rings B include benzyl, substituted phenyl, naphthyl, substituted naphthyl 315064 200418865, furanyl, substituted furanyl, benzofuranyl, substituted benzopyranyl, thienyl , Substituted thienyl, benzothienyl, substituted benzothienyl, and the like. Examples of substituents on substituted phenyl, substituted naphthyl, substituted sulfanyl, substituted benzofluorenyl, substituted thienyl, and substituted benzothienyl are Those mentioned as substituted aryl or heteroaryl in formula (II). Specific examples of the trivalent hexabud n-metallated iridium complex shown by the formula (II) include the following compounds (Π-i) to (Π-xvi).
18 315064 200418865 (IH) (lHi)18 315064 200418865 (IH) (lHi)
(IHii) (IHv) ,.N? .0 rV ^ Cl ' rV ' Cl \ X S 2 2 2 \=J (H - v) (Π - vi)(IHii) (IHv), .N? .0 rV ^ Cl 'rV' Cl \ X S 2 2 2 \ = J (H-v) (Π-vi)
- - - _ _ cx / Λ vs v Ι^ι] ><〇!>< S 〇s C "χ ρ vs ( }={ u ———— 2 一 一 2 一 一 2 一 一---_ _ cx / Λ vs v Ι ^ ι] > < 〇! > < S 〇s C " χ ρ vs () = {u ———— 2 1 1 2 1 1 2 1 One
(Il-vii)(Il-vii)
(1 卜 viii) ~~ 1 (Λΐ m >IrCC,>< w Cl Yy 19 315064 200418865 (ϊΗχ)(1 b viii) ~~ 1 (Λΐ m > IrCC, > < w Cl Yy 19 315064 200418865 (ϊΗχ)
(I卜 x) rS An" yV U V _ _ 2 F(I 卜 x) rS An " yV U V _ _ 2 F
(Π - xi)(Π-xi)
(Π-χίί)(Π-χίί)
(Il-xiii) f 0 〇2NtS i^Y^CH3 Ϋ Ύ rV Cl Η3〇γΛ^ 0 0 J (ΙΙ-χν)(Il-xiii) f 0 〇2NtS i ^ Y ^ CH3 Ϋ Ύ rV Cl Η3〇γΛ ^ 0 0 J (ΙΙ-χν)
(Π-xiv)(Π-xiv)
由本發明所產生之式(III)所示之三價六芽正-金屬化 20 315064 200418865 銥錯合物中:In the trivalent hexabud n--metallization of formula (III) produced by the present invention 20 315064 200418865 iridium complex:
(其中環B與C、b R、R與H3各定義如前述),各個基團, 亦即,環B、環Γ p甘 _ 衣L、:):元基、烷氧基、芳基、與雜芳基,皆 兵刖式(II)中所述相同。該等基團可進4由取代基或包括 在式(II)之經取代芳基或雜芳基中所述之取代基取代。較佳 取代基包括例如龜;5^ ^ ^ ^ 亂原子、氣原子與溴原子之齒素原子,其 取代基可舉例如南、Ρ其 . ^ 戈®说基、鹵烷氧基、ii芳基、與||化雜芳 基0 、 弋(I)由反、尺與所示之烧基可為直鏈或歧鏈 或環狀基’例如,冑1至6個碳原子之烧基。烧基之具體 :包括曱基、乙基、正丙基、2-丙基、正丁基 '第二丁基、 共丁基、弟三丁基、正戊基、2-戊&、第三戊基、2-甲基 丁基、3/曱基丁基、2 = 2-二曱基丙基、正己基、2-己基、3· 己基第—己基、2_己基戊基、3_曱基戊基、4-曱基戊基、 曱基戍-3-基、環丙基、環丁基、環戊基、環己基等。鹵 化烷基包括’例如,含有i至6個碳原子而經】或2或 個鹵素原子鹵化之前述烷基(例如,氟化、氣化、溴化、 I、化)。鹵化:):元基之具體例包括氯曱基、溴曱基、三氟曱基 2-氣乙基、3-氣丙基、3_漠丙基' 3,3,3_三氧丙基等。芳 包括,例如’含有6至14個碳原子之芳基。芳基之具體 315064 21 匕括本基、萘基、¥基等。x 或多環芳香族雜 "’為5-或6_員單環 原子及/… 有,例如,1至3個氮原子、氧 基I: :::雜原子。雜芳基之具體例包括批。定 并嚷吩二Π基心編、綱喃基、心^ 環可為單或以"3 一起形成環時,該等 -、.、早衣或夕核,而較佳為5_或6_員 體例為環戊烷、環己烷等。 所形成裱之具 包括=)所示之三價六芽正-金屬化銀錯合物之較佳例 匕括由下式(XII)所示者··(Wherein Ring B and C, b R, R, and H 3 are each as defined above), each group, that is, ring B, ring Γ p and γ-L, :): member group, alkoxy group, aryl group, It is the same as the heteroaryl group described in Formula (II). These groups may be substituted with a substituent or a substituent described in a substituted aryl or heteroaryl group of formula (II). Preferred substituents include, for example, turtles; 5 ^ ^ ^ ^ chaotic atoms, gas atoms and bromine atoms of the halogen atom, the substituents can be, for example, Nan, P Qi. ^ Ge ® said, haloalkoxy, ii aromatic A radical, and || heteroaryl 0, fluorene (I) is represented by a trans, a rule, and a calcined group may be a straight or branched chain or a cyclic group, for example, a calcined group of 1 to 6 carbon atoms. Specific examples of alkyl groups: fluorenyl, ethyl, n-propyl, 2-propyl, n-butyl 'second butyl, co-butyl, tert-butyl, n-pentyl, 2-pentyl & Tripentyl, 2-methylbutyl, 3 / fluorenylbutyl, 2 = 2-difluorenylpropyl, n-hexyl, 2-hexyl, 3.hexyl-hexyl, 2-hexylpentyl, 3_ Fluorenylpentyl, 4-fluorenylpentyl, fluorenylfluoren-3-yl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and the like. The halogenated alkyl group includes, for example, the aforementioned alkyl group (e.g., fluorinated, gasified, brominated, I, halogenated) containing 1 to 6 carbon atoms and halogenated with 2 or 5 halogen atoms. Halogenation :): Specific examples of the elementary group include chlorofluorenyl, bromofluorenyl, trifluorofluorenyl 2-aminoethyl, 3-aminopropyl, 3-methoxypropyl '3,3,3_trioxypropyl Wait. Aryl includes, for example, 'aryl groups containing 6 to 14 carbon atoms. Specific aryl groups 315064 21 Basic, naphthyl, ¥ and so on. x or polycyclic aromatic hetero " ’is a 5- or 6-membered monocyclic atom and /… Yes, for example, 1 to 3 nitrogen atoms, oxygen I :::: heteroatom. Specific examples of the heteroaryl group include a batch. When the ring is singular, the basic ring, the sulfanyl group, and the ring can be single or ring together with " 3, such as-,., Morning clothes or evening nucleus, and preferably 5_ or 6 _ Member system is cyclopentane, cyclohexane and so on. The formed fixtures include the preferred examples of the trivalent six-bud n-metal silver complex shown by =). The brackets are represented by the following formula (XII) ...
(其中R、R9、R】°、Rn、R1、R2、R3與環b各個定義如前 述’而% B可與結合至環B之吡啶基一起形成環)。 車乂 4之環B包括笨基、經取代之苯基、萘基、經取代 之g基D夫喃基、經取代之卩夫喃基、苯并呋喃基、經取代 之苯并卩夫淹基、噻吩基、經取代之噻吩基、苯并噻吩基、 經取代之笨并噻吩基等。在經取代之苯基、經取代之萘基、 經取代之^ °南基、經取代之苯并呋喃基、經取代之噻吩基、 與取代之笨并噻吩基上之取代基可示例為在式(II)中經取 代之芳基或雜芳基所提及者。 式(π】)所示之三價六芽正_金屬化銥錯合物之具體例 29 315064 200418865 包括下列化合物(ΠΙ-i)至(ΙΠ-xvi)。 (ΠΗ)(Wherein R, R9, R] °, Rn, R1, R2, R3, and ring b are each as defined above and% B may form a ring together with a pyridyl group bound to ring B). Ring B of Cheryl 4 includes benzyl, substituted phenyl, naphthyl, substituted g-group D-furanyl, substituted fluoranyl, benzofuranyl, substituted benzofluorin Group, thienyl, substituted thienyl, benzothienyl, substituted benzothienyl, and the like. Substituents on substituted phenyl, substituted naphthyl, substituted amino, substituted benzofuranyl, substituted thienyl, and substituted benzothienyl can be exemplified as Those mentioned as substituted aryl or heteroaryl in formula (II). Specific examples of the trivalent hexabud n-_metallized iridium complex shown by formula (π)) 29 315064 200418865 include the following compounds (III-i) to (III-xvi). (ΠΗ)
ChU CH, (IIHi)ChU CH, (IIHi)
(ΙΠ-iv)(ΙΠ-iv)
(Ilhv)(Ilhv)
(III-vi)(III-vi)
(II卜 viii)(IIb viii)
」1 23 315064 200418865 (ΙΠΗχ)'' 1 23 315064 200418865 (ΙΠΗχ)
(ΙΙΙ-χ)(ΙΙΙ-χ)
—1 2—1 2
(ΙΙΙ-χί) (ΠΙ-χϋ)(ΙΙΙ-χί) (ΠΙ-χϋ)
(ΙΙΙ-xiii)(ΙΙΙ-xiii)
(ΙΙΙ-xiv)(ΙΙΙ-xiv)
24 315064 200418865 由本發明之製造方法所產生之式(IV)所示之三價六芽 正-金屬化銥錯合物中:24 315064 200418865 In the trivalent hexabud ortho-metalized iridium complex shown by formula (IV) produced by the manufacturing method of the present invention:
(之其:與環C與前述定義相同;環〇表視需要經取代 與式二:;環B與環C可彼此形成稠合環),冑B與環C (U)中定義相同。3玫入 環或縮合環,其丨或/、 έ有°比咬環’其可為單環、多 代美、、☆古 八^ 或多個氫原子可經取代基取代。取 錯八铷制 武(IV)所不之三價六芽正金屬化銥 箱口物製造之反應無負 ^ Λ ^ rr 、放果者^可。該等取代基可示例 句在式(II)中經取代之芳其^ + 方基或雜芳基所提及者。 式(IV)所示之三價丄玆τ Α 向扛山 、/、牙正-金屬化銥錯合物之具體例 匕括由下式(XIII)所示之錯合物:(Which is the same as ring C with the foregoing definition; ring 0 is optionally substituted with formula two :; ring B and ring C may form a fused ring with each other), and 胄 B is the same as defined in ring C (U). 3 A fused ring or a condensed ring, which may be a monocyclic ring, a multi-dimensional ring, or an ancient ring, or a plurality of hydrogen atoms may be substituted by a substituent. Take the wrong Hachiman system. Martial arts (IV) does not have a negative response to the manufacture of trivalent six buds positive metallized iridium box mouthpieces. ^ Λ ^ rr, the fruit holder ^ is acceptable. Such substituents may be exemplified by those mentioned in the formula (II) which are substituted by a aryl group or a heteroaryl group. Specific examples of the trivalent 丄 τ Α Xiang Xiangshan, /, ortho-metallized iridium complexes represented by formula (IV) include the complexes represented by the following formula (XIII):
(其中R4、R5、R6與汉7各 ^ A ^ ^ ^ ^ 地表氫原子、烷基、烯基、 硏基、芳基、雜方基、烷最 1 ^ ^ ^ η . 土少元硫基、氰基、醯基、:); 虱板基、硝基、或鹵素原子· Μ , , ,R、R9、R〗〇、Rn 與環 Β 戈 我如珂述)。 315064 25 200418865 式(XIII)中由 R8、R9、R]〇、R11、R4、R5、R6 與 R7 所 示之烧基、稀基、炔基、芳基、雜芳基、烧氧基、烧硫基、 醯基、與烷氧羰基與前述相同。該等基團可有加成取代基 或取代基,而取代基之示例為在式(II)中經取代之芳基或雜 芳基所提及者。 較佳的環B包括苯基、經取代之苯基、萘基、經取代 之萘基、呋喃基、經取代之呋喃基、苯并呋喃基、經取代 0之苯并呋喃基、噻吩基、經取代之噻吩基、苯并噻吩基、 經取代之苯并噻吩基等。在經取代之苯基、經取代之萘基、 經取代之呋喃基、經取代之苯并呋喃基、經取代之噻吩基、 與經取代之苯并噻吩基上之取代基之示例為在式(II)中經 取代之芳基或雜芳基所提及者。 式(IV)所示之三價六芽正金屬化銥錯合物之具體例為 下列化合物(IV-i)至(IViiii)。(Where R4, R5, R6 and Han 7 each have A ^^^^^^ surface hydrogen atom, alkyl, alkenyl, fluorenyl, aryl, heterosexyl, alkane 1 ^^^^. , Cyano, fluorenyl, :); castanyl, nitro, or halogen atom · M,,, R, R9, R〗 〇, Rn and ring B (as described by Ke Ko). 315064 25 200418865 In formula (XIII), an alkyl group, a dilute group, an alkynyl group, an aryl group, a heteroaryl group, an alkyl group, an alkyl group, an alkyl group, an alkyl group, an alkyl group, an alkynyl group, an aryl group, an alkoxy group, The thio group, the fluorenyl group, and the alkoxycarbonyl group are the same as described above. These groups may have addition substituents or substituents, and examples of the substituents are those mentioned as substituted aryl or heteroaryl groups in formula (II). Preferred ring B includes phenyl, substituted phenyl, naphthyl, substituted naphthyl, furanyl, substituted furanyl, benzofuranyl, substituted benzofuranyl, thienyl, Substituted thienyl, benzothienyl, substituted benzothienyl, and the like. Examples of substituents on substituted phenyl, substituted naphthyl, substituted furanyl, substituted benzofuranyl, substituted thienyl, and substituted benzothienyl are in the formula: References to substituted aryl or heteroaryl in (II). Specific examples of the trivalent hexabud orthometalated iridium complex shown by the formula (IV) are the following compounds (IV-i) to (IViiii).
26 3]5064 200418865 (IV-i)26 3] 5064 200418865 (IV-i)
(IV-iii)(IV-iii)
(IV—v)(IV-v)
(IV - vii)(IV-vii)
OVHi)OVHi)
由本發明之製造方法所產生之式(V)所示之三價六芽 27 315064 正'金屬化銥錯合物中:In the trivalent six buds represented by formula (V) produced by the manufacturing method of the present invention 27 315064 In the '' metalized iridium complex:
(其中環Β盥 m,、 ”衣L各如前述定義),環B與環C如前述定義。 式(V)之較枯二 α 一 二彳貝六芽正-金屬化銥錯合物包括由下式(XIV) 所示者:(Wherein ring B, m, and L are each as defined above), and ring B and ring C are as defined above. The heavier di-α-dipyridine hexa-n-metallated iridium complex of formula (V) includes By the following formula (XIV):
(其中R、R9、R】0、Rn與環B各如前述定義;環B f與 結合至環B之吡啶基形成環)。 幸乂 ^之被B包括苯基、經取代之笨基、萘基、經取代 之奈基、呋喃基、經取代之呋喃基、苯并呋喃基、經取代 之苯并卩夫喃基、噻吩基、經取代之噻吩基、苯并噻吩基、 經取代之笨并噻吩基等。在經取代之苯基、經取代之萘基、 經取代之呋喃基、經取代之苯并呋喃基、經取代之噻吩基、 與經取代之笨并噻吩基上之取代基可示例為在式(II)中經 取代之芳基或雜芳基所提及者。 28 3】5064 200418865 式(V)所示之三價六芽正-金屬化銥錯合物之具體例為 下列化合物(V-i)至(V-X)。 (VH) (VHi) /=\ j 1 γ- 、:Tr 〉Ir cV y j 3 3 (V - iii) (VHv)(Wherein R, R9, R] 0, Rn and ring B are each as defined above; ring B f and pyridyl bonded to ring B form a ring). Fortunately, B is phenyl, substituted naphthyl, naphthyl, substituted naphthyl, furanyl, substituted furanyl, benzofuranyl, substituted benzofluoranyl, thiophene Group, substituted thienyl, benzothienyl, substituted benzothienyl, and the like. Substituents on substituted phenyl, substituted naphthyl, substituted furanyl, substituted benzofuranyl, substituted thienyl, and substituted benzothienyl can be exemplified by the formula References to substituted aryl or heteroaryl in (II). 28 3] 5064 200418865 Specific examples of the trivalent hexabud n-metallated iridium complex represented by the formula (V) are the following compounds (V-i) to (V-X). (VH) (VHi) / = \ j 1 γ- : Tr > Ir cV y j 3 3 (V-iii) (VHv)
」3"3
(V-v) (V-vi) fa Λ Λ Ti ^>Ir iV ifV — — 3 1— — (VHx)(V-v) (V-vi) fa Λ Λ Ti ^ > Ir iV ifV — — 3 1 — — (VHx)
(V-vii) (V,)(V-vii) (V,)
下面將解說在本發明方法中使用作為起始物之式(VI) 至(VIII)所示化合物。 本發明製造方法之配位化合物意指含有能形成銥錯合 物配位體之化學結構之化合物。該等化合物包括能全部成 為錶錯合物配位體之配位化合物,或由配位化合物中留下 部分原子或原子基團而用於银錯合物形成配位體。 315064 29 十丄OOUJ) 十丄OOUJ) 示化合物中 使用於本發明方法之式(VI)所The use of compounds represented by formulae (VI) to (VIII) as starting materials in the method of the present invention will be explained below. The complex compound in the production method of the present invention means a compound containing a chemical structure capable of forming an iridium complex ligand. These compounds include coordination compounds that can all become complex ligands of the epi-complex, or a part of atoms or atomic groups left in the coordination compound for use in silver complex formation ligands. 315064 29 Deca OOUJ) Deca OOUJ) is used in the compound of formula (VI) in the method of the present invention.
Ή (VI) 環Β與環C如前述定義 由下式(XV)所示之合物 (其中環Β與環C各如前述定義) 式(VI)所不化合物之較佳例包括Ή (VI) Ring B and ring C are as defined above. The compound represented by the following formula (XV) (where ring B and ring C are each as defined above). Preferred examples of compounds not represented by formula (VI) include
(XV) 美、中 R、R °與R"各自獨立地表氫原子、烷基、烯 二::基、芳基、雜芳基、烷氧基、烷硫基、氰基、醯基、 其氡%基硝基、或齒素原子;環B表視需要經取代之芳 土或雜芳基;或環B可與連結至環3之吡咬基形成環)、 Λ j(XV)中由R8、R9、R】〇與R"所示之烷基、烯基、炔 卜、芳基、雜芳基、炫氧基”完硫基、S!基、與烧氧羱基 口有力成取代基或多個取代基,而取代基之示例為在式(H) 中經取代之芳基或雜芳基所提及者。 較佳的環B包括苯基、經取代之苯基、萘基、經取代 之奈基、呋喃基、經取代之呋喃基、苯并呋喃基、經取代 之苯并呋喃基、噻吩基、經取代之噻吩基、苯并噻吩基、 取代之苯并噻吩基等。在經取代之苯基、經取代之蔡基、 、、二取代之D夫喃基、經取代之苯并呋喃基、經取代之噻吩基、 興取代之苯并噻吩基上之取代基可示例為在式(Π)中經取 30 315064 200418865 代之芳基或雜芳基所提及者。 式(VI)所示化合物之具體例為下列化合物(VI-i)至 (VI-xxvii) 〇 31 315064 200418865(XV) American, Chinese R, R ° and R " each independently represent a hydrogen atom, an alkyl group, an alkenyl :: group, an aryl group, a heteroaryl group, an alkoxy group, an alkylthio group, a cyano group, a fluorenyl group,氡% nitro group, or halo atom; ring B represents optionally substituted aryl or heteroaryl; or ring B may form a ring with a pyridyl group linked to ring 3), Λ j (XV) R8, R9, R] 0 and R " alkyl, alkenyl, alkynyl, aryl, heteroaryl, xyloxy "thiol, S! Group, and thiol are strongly substituted Or a plurality of substituents, and examples of the substituents are those mentioned as substituted aryl or heteroaryl in formula (H). Preferred ring B includes phenyl, substituted phenyl, naphthyl , Substituted naphthyl, furanyl, substituted furanyl, benzofuranyl, substituted benzofuranyl, thienyl, substituted thienyl, benzothienyl, substituted benzothienyl, etc. Substituents on substituted phenyl, substituted zeenyl, disubstituted fluoranyl, substituted benzofuranyl, substituted thienyl, and substituted benzothienyl may be Examples are those mentioned in formula (Π) by 30 315064 200418865 substituted aryl or heteroaryl. Specific examples of compounds represented by formula (VI) are the following compounds (VI-i) to (VI-xxvii) 〇31 315064 200418865
(VI—V)(VI-V)
(VI—vi) (VI—vii) (VI—viii) (VI—ix) (VI—x)(VI-vi) (VI-vii) (VI-viii) (VI-ix) (VI-x)
32 315064 200418865 (vhxi)32 315064 200418865 (vhxi)
Me〇Me〇
ClCl
(V 卜 xxvi)(V BU xxvi)
Me〇2cMe〇2c
CFaCFa
MeO (V 卜 χχνϋ)MeO (V 卜 χχνϋ)
使用於本發明方法之式(vn)所示化合物中: R1Used in the compound represented by formula (vn) in the method of the present invention: R1
(VH) (其中 R ]、p 2 4 * 與R3各與前述定義相同),烷基、烷氧基、 方基與雜芳其π 、 土了有一個加成取代基或多個取代基,該等取 代基可相同於式(ΠΙ)中所提及者。此外,式(VII)所示化合 物中由R】、與R3所示基團也可相同於(ΠΙ)中所提及者。 使用於本發明中式(VII)所示化合物之示例為乙醯基 丙酮、1乙醯基環己酮、2-三氟乙醯基環戊酮、丨,弘二笨基 丙二_、2,2,6,6•四甲基_3,5·庚二酮、%甲基4,心戊二(VH) (wherein R], p 2 4 * and R3 have the same definitions as above, alkyl group, alkoxy group, square group and heteroaryl group each have π, and there is one addition substituent or multiple substituents, These substituents may be the same as those mentioned in formula (III). In addition, in the compound represented by formula (VII), the group represented by R] and R3 may be the same as those mentioned in (III). Examples of the compound represented by the formula (VII) used in the present invention are acetamylacetone, 1ethylammonylcyclohexanone, 2-trifluoroacetamylcyclopentanone, Benzodipropylpropane, 2,2 , 6,6 • Tetramethyl-3,5 · heptanedione,% methyl 4, cardiopentane
勹勹 JO 315064 200418865 酮、1,M,5,5,5-六氟 ^ ^ ^ 耽2,4“戊二酮、卜苯基-1,3-丁二酮、;[一 呋喃基-1,3-丁二·等。 使用於本發明古、+ 万去之式(VIII)所示化合物中勹 勹 JO 315064 200418865 ketone, 1, M, 5,5,5-hexafluoro ^ ^ ^ 2,4 "pentanedione, phenylphenyl-1,3-butanedione, [monofuranyl-1 , 3-butadiene, etc. It is used in the compound represented by formula (VIII) of the present invention.
(VIII) 相同 較佳 (其中環D與前述定義 _式(VIII)所示化合物之 缓酸或其衍生物: )’環D相同於式(IV)所提及者 例包括由下式(XVI)所示之咄(VIII) The same is preferred (wherein ring D is the same as the delayed acid or a derivative of the compound represented by formula (VIII) :) Ring D is the same as those mentioned in formula (IV). Examples include the following formula (XVI As shown
R6R6
R5 R4 (XVI) (其中R、R、R6與R7各自獨立地表氫原子、烷基、烯基、 炔基、芳基、雜芳基、烷氧基、烷硫基、氰基、醯基、烷 _氧羰基、硝基、或鹵素原子)。 式(XVI)之R4、R5、R6與R7中,烷基、烯基、炔基、 芳基、雜芳基、烷氧基、烷硫基、醯基、烷氧羰基皆與前 述相同。該等基團可有加成取代基或多個取代基,而取代 基可舉示例為在式(II)中經取代之芳基或雜芳基所提及 者。 式(VIII)所示化合物之具體例為下列化合物(VIn_i)至 (VIIl:vii) 0 315064 34 200418865R5 R4 (XVI) (wherein R, R, R6 and R7 each independently represent a hydrogen atom, alkyl, alkenyl, alkynyl, aryl, heteroaryl, alkoxy, alkylthio, cyano, fluorenyl, Alkoxycarbonyl, nitro, or halogen). In R4, R5, R6 and R7 of the formula (XVI), the alkyl, alkenyl, alkynyl, aryl, heteroaryl, alkoxy, alkylthio, fluorenyl, and alkoxycarbonyl groups are the same as described above. These groups may have an addition substituent or a plurality of substituents, and the substituents may be exemplified by those mentioned as substituted aryl or heteroaryl groups in formula (II). Specific examples of the compound represented by the formula (VIII) are the following compounds (VIn_i) to (VIIl: vii) 0 315064 34 200418865
(vm — i) (VIH-ii) (VIH—iii) (VIH—iv)(vm — i) (VIH-ii) (VIH—iii) (VIH—iv)
(VIII-vi) (VIHiii) (VIH—v)(VIII-vi) (VIHiii) (VIH-v)
本發明之方法將根據反應略圖1至4以下列項目1)至 4)加以說明。 1) 略圖1說明以式(I)之單價銥二核錯合物作為起始 化合物而產生式(II)之三價六芽正-金屬化銥二核錯合物之 方法之反應式。 [略圖1]The method of the present invention will be described based on the reaction schemes 1 to 4 and the following items 1) to 4). 1) Figure 1 illustrates the reaction formula of a method of producing a trivalent hexabud n-metallated iridium dinuclear complex of formula (II) using the monovalent iridium dinuclear complex of formula (I) as a starting compound. [Thumbnail 1]
在有或無合適的溶劑中且必要時在鈍氣環境中,將式 (1)所示之單價銥二核錯合物與式(VI)所示化合物反應,而 35 315064 418865 輕易地產生式(II)所示之 物。 j貝六芽正金屬化銥二核錯合 至於式(I)所示之罩彳&贫— 物之量,相對於式α s合物與式(VI)所示化合 (VI)所示化人’7化合物之單價銥二核錯合物,式 』/1丁化口物一般使用量為合 1,較佳地由…。當量,更佳二自:::量2… _中,=方:較佳地係在溶劑存在下進行在此步驟 ► 口 I使用之溶劑例如,如N 一 或-甲其^於 一甲基甲^胺、甲醯胺、 合物;如1ΨΘ 7 己腈之含氰基之有機化 鄰-二氣笨::,2_二氯乙燒、氯仿、四氯化碳、或 —鼠本之齒化烴;如戊烷、己烷、庚烷、辛 之脂肪族烴、如笼、田# 戍六烧 驗、 本甲本、或二甲苯之芳香族烴;如二乙 ’、一異丙醚、第三丁基曱基醚、二甲氧 。南Ά二氧陸園或13_1&f(13d 知、四氫口夫 如不 飞i,3 一乳戊^(1,3-dlox〇丨a】ie)之醚類. 如丙綱或甲基乙基酮之酮類;如甲 力員, _ ^ 。恥 2 ·丙醇、工 I -手、第三丁醇、或1乙氧基乙醇之醇類;如 一 3K含 一^岛子、 -子、1,2-丙二醇、或甘油之多元醇;或水。誃 w 星雜斗、人、, ΠΛ 4〆谷劑可 、,3、5併2或多種使用。該等溶劑中,較佳為單獨或八 併2或多種使用例如曱醇、乙醇、’丙醇、正 5 丁旷 畔、第三 二或2-乙氧基乙醇之醇類;例如乙二醇、丙二醇”二 一 s子、或甘油之多元醇;及水。 只要能令人滿意地推動反應,在溶劑使用| 至工亚無限 制’相對於1份式⑴所示之單價銥二核錯合物,复— 用旦+ /、 般使 里在1至2 0 0份,較佳約5至5 〇份。 315064 36 200418865 在削迷步驟中,反應較佳地係在鈍氣環境中進行 作 為鈍氣可舉例如可使用氮氣、氬氣等。反應也可結合超音 波產生器進行。 ° 反應溫度通常選自由25t至300t的範圍,較佳由6〇 C至200°C,而更佳由80°c至15〇〇c。 反應時間通常選自由10分鐘至72小時的範圍,較佳 由30分鐘至μ小時,更佳由1至6小時。 乂 土 所得產物較佳地係在無後處理下使用於後續反應 然而必要時也可進行後處理單離與純化。可進行之:扭 例如將反應產物萃取、沉;殿過濟、 Μ 处 瘵發等。這些操作可單獨或合併 ^ 合併例如管柱層析、再結晶、昇華等完成, 或 2)略圖2顯示以式(I)所示之單 起始物而製造式(III)所示之二價丄一、’(一 /錯合物作為 之方法之反應式。 七牙正-金屬化銀錯合物 315064 37 200418865 [略圖3The monovalent iridium dinuclear complex represented by formula (1) is reacted with a compound represented by formula (VI) in the presence or absence of a suitable solvent and, if necessary, in an inert atmosphere, and 35 315064 418865 easily produces the formula (II) What is shown. j Bayliuya orthometallized iridium dinuclear is mismatched with respect to the amount of the mask & depleted substance represented by formula (I), relative to the compound of formula α s and compound (VI) represented by formula (VI) The monovalent iridium dinuclear complex of Huaren'7 compound, the formula "/ 1" is generally used in the amount of 1, but preferably from ... Equivalent, better two ::: Amount 2 ... _ in, = square: preferably performed in the presence of a solvent at this step ► Solvents used in the mouth, for example, such as N- or -methyl its ^ in monomethyl Methylamine, formamidine, compounds; such as 1ΨΘ 7 Hexonitrile-containing cyano-organic o-dichlorobenzene: 2, 2-dichloroethane, chloroform, carbon tetrachloride, or- Toothed hydrocarbons; such as pentane, hexane, heptane, octane aliphatic hydrocarbons, such as cages, Tian # 戍 六 烧 测, benzyl, or xylene aromatic hydrocarbons; such as diethyl ', isopropyl Ether, third butyl fluorenyl ether, dimethoxy. Nanxun Dioxin Luyuan or 13_1 & f (13d known, tetrahydrocoated if not flying i, 3 a lactam ^ (1,3-dlox〇 丨 a) ie) ether. Such as Clan or methyl Ketones of ethyl ketones; such as nail fighters, _ ^. Shame 2. Propanol, I-hand, tertiary butanol, or 1 ethoxy ethanol alcohols; such as a 3K containing a ^ island,- , 1,2-propanediol, or glycerol polyhydric alcohol; or water. 誃 w star bucket, human, ΠΛ 4 gluten can be used, 3, 5, and 2 or more. Among these solvents, preferred Alcohols such as methanol, ethanol, 'propanol, n-butanol, tertiary or 2-ethoxyethanol; alone or octane 2 or more; for example, ethylene glycol, propylene glycol " , Or glycerol polyhydric alcohol; and water, as long as the reaction can be satisfactorily promoted, the use of solvents | to the sub-Asian unlimited 'with respect to 1 part of the monovalent iridium dinuclear complex shown in formula ⑴, complex — use denier + / 、 Generally, it is 1 to 200 parts, preferably about 5 to 50 parts. 315064 36 200418865 In the obliteration step, the reaction is preferably performed in an inert atmosphere. As an inert gas, for example, Use nitrogen, argon, etc. The reaction can also be performed in combination with an ultrasonic generator. ° The reaction temperature is usually selected from the range from 25t to 300t, preferably from 60C to 200 ° C, and more preferably from 80 ° c to 1500c. The reaction time is usually selected The free range is from 10 minutes to 72 hours, preferably from 30 minutes to μ hours, more preferably from 1 to 6 hours. The product obtained from vermiculite is preferably used in subsequent reactions without post-treatment, but can also be carried out if necessary. Treatment of isolation and purification. It can be carried out: for example, extraction and precipitation of reaction products; Dian Guoji, eruption at M, etc. These operations can be performed separately or combined ^ Combined such as column chromatography, recrystallization, sublimation, etc., Or 2) Sketch 2 shows the reaction formula for the method of producing the bivalent 丄 a, '(a / complex) represented by formula (III) from a single starting material represented by formula (I). 七 牙 正- Silver metallized complex 315064 37 200418865 [schema 3
*百先,根據顯示於略圖1之方法,在有或無合適的溶 J中且必要%在鈍氣環境中,將式⑴所示之單價二核銥錯 合物與式(VI)所示化合物反應,而輕易地產生式(Π)所示之 三價六芽正-金屬化銥二核錯合物。 4妾 1 在有或無合適的溶劑中且必要時在鹼存在下及 必要日可在純氣環境中,將所得之式(II)所示之三價六芽正-金屬化銀二核錯合物與式(νπ)所示化合物反應而溫和地 得到式(III)所示之三價六芽正-金屬化銥二核錯合物。 在此步驟中,式(11)所示之三價六芽正_金屬化銥二核 ί曰。物在進订則述之後處理、單離與純化後,與式(νίΙ)所 不化口物反應。然而在此方法中,適合將三價六芽正金屬 化銥一核錯合物不經任何後處理等而接續著在單〆槽中進 行式(11)所示化合物與式(VII)所示化合物之反應(亦即,單 315064 38 200418865 槽反應)。 式(v^)所厂、)所不化合物與鹼可分開加至反應介質中,或者 μ 一丁化合物先與鹼反應後再加至反應介質中。當式 (VII)所示化人 、, r° 頁先與後述之鹼,例如乙醯基丙酮鈉、2-乙酿基環已知 〜 、、苯甲醯基丙酮鉀等反應時,可作為式(VII) 所不化合物之衍生物。 之旦、()所不之單價銥二核錯合物與式(VI)所示化合物 方;>面,相對於式⑴所示之單價銥二核錯合物而言,式 所不化合物之使用量合適地選自由2至50當量的範 ㈤’較佳地為^ 馬3至20當$,而更佳地為4至6當量。 所八相對於式⑴所示之單價銥二核錯合物而言,式(Vn) Α 2化合物一般使用量約1至20當量,較佳為Κ5至1() 备量,而更佳為2至3當量。 _ 在此方法中,反應較佳地係在鹼存在下進行。以驗而 二’可舉例有無機鹼及有機鹼。無機鹼包括氫氧化鈉、气 " 、甲 氣氧化經、碳酸納、碳酸舒、碳酸氫納、碳酸氡 卸、以及例如氫化鈉之金屬氫化物等。有機鹼包括例如甲 ®子鮮、曱醇鈉、曱醇鋰、乙醇鈉及第三丁醇鉀之鹼金屬烧 氧化物;以及例如三乙胺、二異丙基乙胺、N,N•二甲基苯 月女、六氫吡啶、吡啶、心二曱基胺基吡啶、1,5〜二氮雜雙 裒[4.3.0]壬-5-烯、二氮雜雙環[5.4.0]十一 -7、稀、二 正丁基胺及N-曱基嗎啉之有機胺類。 相對於式(VII)化合物而言,鹼之一般使用量為合適地 選自由0.5至10當量,較佳地為0·8至2當量,而更較佳 39 315064 200418865 地為1至1·2當量的範圍。 例如氮氣 可使用如 此方法中,反應較佳係在鈍氣環境中進行 或氬氣。再者,反應可利用超音波產生器進行 在此方法中,適合使用溶劑。就溶劑而言 略圖1中所舉之示例。 反應溫度一般選自由溫度範圍2 5 °c至3 〇 0 V 〇 I,車交佳土士 由6〇。0至200。(:,而更較佳地由8〇。〇至丨50它。 丨 反應時間一般選自由3分鐘至48小時的笳R λ 炎m 了 ]軌圍,較佳地 馮1〇分鐘至24小時,更較佳地為3〇分鐘 土 J 小時。 接著將所得之式_所示之三價六芽正_金屬化銀錯 ^進行如略圖1所述之後處理,單離及純化而提供碟光 〇)略圖3顯示以式⑴所示之單價銥二核錯合物作為 起始物而產生式(IV)所示之三價六芽正-金屬化銀 錯合物之製造方法之反應序列。 315064 40 200418865* Bai Xian, according to the method shown in Figure 1, in the presence or absence of an appropriate solvent J and necessary% in a passive atmosphere, the monovalent dinuclear iridium complex shown in formula (1) and formula (VI) The compound reacts to easily produce a trivalent hexabud n-metallated iridium dinuclear complex represented by the formula (Π). 4 妾 1 In the presence or absence of a suitable solvent and if necessary in the presence of a base and in a pure gas environment, the trivalent hexabud positive-silver metal dinuclear obtained in the formula (II) can be dissociated The compound is reacted with a compound represented by the formula (νπ) to obtain a trivalent hexabud n-metallated iridium dinuclear complex represented by the formula (III). In this step, the trivalent six bud positive-metallized iridium dinuclear represented by formula (11) is said. After the product is processed, separated and purified, it reacts with the chemical compound of formula (νίΙ). However, in this method, it is suitable to carry out the compound represented by formula (11) and the formula (VII) in a single hafnium trough without any post-treatment, etc. Compound reaction (ie, single 315064 38 200418865 tank reaction). Compounds of formula (v ^) and) can be added to the reaction medium separately, or the μ-butyl compound can be added to the reaction medium after reacting with the base. When the formula (VII) is modified, the r ° page is first reacted with a base described later, for example, sodium acetoacetone, 2-ethyl ethyl ring is known to ~, potassium benzylacetone, etc. Derivatives of compounds not represented by formula (VII). Once, the monovalent iridium dinuclear complex not represented by () and the compound represented by formula (VI); > face, compared to the monovalent iridium dinuclear complex represented by formula ⑴, the compound not represented by formula The amount used is suitably selected from the range of 2 to 50 equivalents, preferably 3 to 20 equivalents, and more preferably 4 to 6 equivalents. Compared with the monovalent iridium dinuclear complex shown by formula (I), the compound of formula (Vn) A 2 is generally used in an amount of about 1 to 20 equivalents, preferably κ5 to 1 () in reserve, and more preferably 2 to 3 equivalents. In this method, the reaction is preferably performed in the presence of a base. As a rule, two 'can be exemplified by inorganic bases and organic bases. Inorganic bases include sodium hydroxide, gas, carbon dioxide, sodium carbonate, sodium carbonate, sodium bicarbonate, tritium carbonate, and metal hydrides such as sodium hydride. Organic bases include alkali metal oxides such as formazan, sodium alkoxide, lithium alkoxide, sodium ethoxide, and potassium tert-butoxide; and for example, triethylamine, diisopropylethylamine, N, N • di Methylbenzene, hexahydropyridine, pyridine, cardiobiaminoaminopyridine, 1,5 ~ diazabifluorene [4.3.0] non-5-ene, diazabicyclo [5.4.0] ten Mono-7, di-, n-butylamine and N-fluorenyl morpholine organic amines. With respect to the compound of formula (VII), the general amount of base used is suitably selected from 0.5 to 10 equivalents, preferably 0.8 to 2 equivalents, and more preferably 39 315064 200418865 to 1 to 1.2 Equivalent range. For example, nitrogen can be used in this method. The reaction is preferably carried out in an inert atmosphere or argon. Furthermore, the reaction can be performed using an ultrasonic generator. In this method, a solvent is suitably used. In terms of solvents, the example given in Figure 1 is sketched. The reaction temperature is generally selected from a temperature range of 25 ° C to 300 V 〇1, Che Jia Jia Tuoshi from 60. 0 to 200. (:, And more preferably from 80.50 to 50. The reaction time is generally selected from 笳 R λ Yan m from 3 minutes to 48 hours] orbital, preferably from 10 minutes to 24 hours , More preferably 30 minutes to J hours. Next, the obtained formula _ is shown as the trivalent hexa bud positive _ metallized silver wrong ^ after processing as described in Figure 1, single isolation and purification to provide disc 〇) Sketch 3 shows the reaction sequence of a method for producing a trivalent hexabud n-silver metal complex represented by formula (IV) using the monovalent iridium dinuclear complex represented by formula (I) as a starting material. 315064 40 200418865
首先,根據顯示於略圖1之方法,在有或無合適的溶 劑中且必要時在鈍氣環境中,將式(I)所示之單價銥二核錯 合物與式(VI)所示化合物反應,而輕易地產生式(II)所示之 三價六芽正-金屬化銥二核錯合物。 接著,在有或無合適的溶劑中且必要時在鹼存在下及 必要時在鈍氣環境中,將所得之式(II)所示之三價六芽正-金屬化銀二核錯合物與式(VIII)所示化合物反應而溫和地 得到式(IV)所示之三價六芽正-金屬化銥二核錯合物。 在此步驟中,式(II)所示之三價六芽正-金屬化鈒二核 錯合物在進行前述之後處理、單離與純化後,與式(VIII) 所示化合物反應。然而在此方法中,適合將三價六芽正-金屬化銥二核錯合物不經任何後處理而接續著在單一槽中 進行式(II)所示化合物與式(VIII)所示化合物之反應(亦 41 315064 200418865 即,單槽反應)。 式(VIII)所示化合物與驗可分開加至反應介質中,或 者式(VIII)所示化合物先與驗反應後再加至反應介質中。 當式(VIII)所示化合物首先與後述之驗,例如甲基卩比啶 納、3 -氣D比σ定_ 2 -緩酸納、5 -苯基D比咬-2 ·緩酸_等反應時, 可作為式(VIII)所示化合物之衍生物。 在式⑴所示之單價银二核錯合物與式(V〗)所示化合物 之量方面,相對於式⑴所示之單價銥二核錯合物而言,式 (VI)所示化合物之使用量合適地選自由2至別當量的範 圍,較佳地為3至20當量,而更佳地為4至6當量。 相對於式(I)所示之單價銥二核錯合物而言,式(νΙΠ) 所示化合物一般使用量約i至20當量,較佳為i 5至ι〇 當量’而更佳為2至3當量。 在此方法中,反應較佳地係在驗存在下進行。以驗而 言,可使用如略圖2中所舉之示例。 …f此方法中反應較佳地係在例如I氣、氩氣等之純氣 壞浼中進行。反應也可結合超音波產生器進行。 二,適合使用溶劑。就溶劑而::可使用如 略圖1中所舉之示例。First, according to the method shown in Fig. 1, a monovalent iridium dinuclear complex of the formula (I) and a compound of the formula (VI) are mixed with a suitable solvent in the presence or absence of a suitable solvent and, if necessary, an inert atmosphere. Reaction, and easily produces a trivalent hexabud n-metallized iridium dinuclear complex represented by formula (II). Next, in the presence or absence of a suitable solvent and, if necessary, in the presence of a base and, if necessary, in an inert atmosphere, the obtained trivalent hexabud n-silver metal dinuclear complex represented by the formula (II) and The compound represented by formula (VIII) reacts gently to obtain a trivalent hexabud n-metallated iridium dinuclear complex represented by formula (IV). In this step, the trivalent hexabud n-metallated europium dinuclear complex represented by the formula (II) is subjected to the aforementioned post-treatment, isolation and purification, and then reacted with the compound represented by the formula (VIII). However, in this method, it is suitable to carry out the compound of formula (II) and the compound of formula (VIII) successively in a single tank without any post-treatment of the trivalent hexabud n-metalized iridium dinuclear complex. Reaction (also 41 315064 200418865 ie single-tank reaction). The compound represented by formula (VIII) can be added to the reaction medium separately from the test, or the compound represented by formula (VIII) can be added to the reaction medium after reacting with the test. When the compound represented by formula (VIII) is first tested with the following, for example, methylpyridine, 3 -gas D ratio σ fixed _ 2-slow acid sodium, 5-phenyl D ratio bite-2 · slow acid _, etc. During the reaction, it can be used as a derivative of the compound represented by the formula (VIII). In terms of the amount of the monovalent silver dinuclear complex represented by formula (VII) and the compound represented by formula (V), the compound represented by formula (VI) is relative to the monovalent iridium dinuclear complex represented by formula (VI) The amount used is suitably selected from the range of 2 to other equivalents, preferably 3 to 20 equivalents, and more preferably 4 to 6 equivalents. Relative to the monovalent iridium dinuclear complex represented by formula (I), the compound represented by formula (νΙΠ) is generally used in an amount of about i to 20 equivalents, preferably i 5 to ι0 equivalents', and more preferably 2 To 3 equivalents. In this method, the reaction is preferably performed in the presence of a test. As a rule of thumb, the example shown in Figure 2 can be used. ... F The reaction in this method is preferably carried out in a pure gas such as I gas, argon gas or the like. The reaction can also be performed in combination with an ultrasound generator. Second, it is suitable to use solvents. For the solvent :: The example as shown in Fig. 1 can be used.
由6代至2峨,而更較佳地由80。(:至l5Qt〇U 反應時間一般選自由3分 。 Λ 10 ^4- 5 , * 至8小捋的範圍,較佳地 為刀知至24小時,更較佳地為3〇分鐘至”時。 接著將所得之式(IV) — 0〜 μ之一彳貝/、牙正—金屬化銥錯 315064 42 200418865 合物進行如略圖丨所述之後處理,單離及純化而提供磷光 物質。 )各圖4 _示以式(I)所示之單價銥二核錯合物作為 起始物而產生式(V)所示之三價六芽正·金屬化銥 錯合物之製造方法之反應式。 [略圖4]From the 6th generation to 2E, and more preferably from 80. (: To 15Qt〇U reaction time is generally selected from 3 minutes. Λ 10 ^ 4- 5, * to 8 hours, preferably from 24 to 24 hours, more preferably from 30 minutes to " Next, the obtained compound of formula (IV) —one of 0 ~ μ 彳 /, orthodontic—metallized iridium 315064 42 200418865 is subjected to post-treatment as described in the sketch, separated and purified to provide a phosphorescent substance.) Each figure 4 _ shows a reaction of a method for producing a trivalent hexabud n-metallized iridium complex represented by formula (V) using the monovalent iridium dinuclear complex represented by formula (I) as a starting material. [Schematic 4]
首先,根據顯示於略圖1之彳法,在有或無合適的溶 川中且义要時在鈍氣環境中,將式⑴所示之單價銥二核錯 c 一式(VI)所不化合物反應,而輕易地產生式(Η)所示之 三價六芽正-金屬化銀二核錯合物。First of all, according to the method shown in Fig. 1, the monovalent iridium dinucleotide c-formula (VI) represented by formula (VI) is reacted in the presence or absence of an appropriate dissolve and in an inert atmosphere, if necessary, The trivalent hexabud n-metal silver dinuclear complex shown in formula (i) is easily produced.
接著 ^ Λ it ^ A 士 有或"、、&適的溶劑中且必要時在鹼存在下及 Ί才在鈍虱環境中,將所得之式(II)所示之三價六芽正_ 金 '化銥二核錯合物與式(VI)所示化合物反應而溫和地得 43 315064 200418865 到式(V)所示之三價六芽正-金屬化銥錯合物。 伊入::步驟中’式⑻所示之三價六芽正-金屬化鉉二核 二在進行前述之後處理、單離與純化後, (VI)所示化AC十 从、 °反應。“而在此方法中,適合將三價六芽 正金屬化鉉-4— ' ' 槽中進 〜^錯合物不經任何後處理等而接續著在單一 (亦即,所示化合物與加至反應槽之銀鹽進行反應 早槽反應)。 反應 銀鹽包g y 例如硝酸銀、醋酸銀 酸銀、三氟曱 酸銀較佳。 再將合物先與式(VI)所示化合物反應後, 反應。 "中,而後再添加式(VI)所示化合物而繼續 氣醋酸銀、甲烧石黃 酸銀專’而以三氟醋酸銀或三氟甲统石备 相對於式 一 至20當量f上所示化合物而言,一般銀鹽可使用量為i 當量、 ,較佳地為i·5至Μ當量,而更佳地為2至3 此反應中 1 如 n主6當量。 在此方法Φ . 反應較佳地係在例如氮氣、氬氣等 言,式m)所_,相對於式⑴所示之單價鉉二核錯合物而 量的範圍,:化合物之使用量合適地選自由4至100當 量。此外,:佳地為6至40當量’而更佳地為8至12 ; 相對於式(1)二式(VI)所示化合物在銀鹽添加後復添加時, 用量係合適::化合物而言’式(VI)所示化合物-般可使 而更佳地為自由2至5〇當量,較佳地為3至]〇當I , 之純 315〇(54 44 200418865 氣環境中進行。反應也可與超音波產生器合併進行。 在此方法中,適合使用溶劑。就溶劑而言,可使用如 略圖1中所舉之不例。反應溫度一般選自由溫度範圍Μ艺 至30〇°c,較佳地由60t:至200t,而更較佳地由8(^至 u〇°c。反應時間一般選自由1〇分鐘至72小時的範圍,較 佳地為^分鐘至48小時,更較佳地為i小時至6小時。 接著將所得之式(V)所示之三價六芽正_金屬化銥錯合 物進行如略圖i所述之後處理,單離及純化而提供麟光物 質。 本發明之方法其特徵在於使用單價銥二核錯合物。因 此,式(Π)、⑽)、(IV)或⑺所.示之三價六芽正_金屬化錶 錯合物可高交文率的產生H匕之外還可能在料中不單 離式(II)之三價六芽正_金屬化二核錯合物之中間體而產生 該等錯合物。本發明之方法其特徵如下。 )可將夕步之反應在相同反應槽與相同溶劑中進 行。 2)不需要一般在中間體合成後例如溶劑回收、後處 理、單離與純化之複雜的操作。 )可將由2)中所述知作所引起之中間體之物理流失 最小化。 4)由於理由⑽3)而能減少中間體與最終產物之成 本。 由本4月之方法所產生之三價六芽正-金屬化银錯合 物有用於作為磷光物。 315064 45 200418865 (實施例) 本t月將以下列貫施例更詳盡地說明而無意於限制本 發明。 在各個貝%例中,S/S表溶劑對於起始單價銥二核錯合 物重i之體積比以毫升/克之單位表示。 φ實施例1 化σ物(IIm)(雙(2-笨基吡錠基-N,C2,)銥氯鹽二聚物) 之製造 在配備有回流冷凝器之史列克氏(Schlenk,s)燒瓶中置 入(1,5-裱辛二烯)銥⑴氯鹽二聚物(2·〇〇克,2 %毫莫耳, 1 s里)而燒瓶内部經氮氣置換。接續地添加2_乙氧基乙醇 (20毫升,s/s:=10)與2_苯基吡啶(2·56毫升,ΐ7·88毫莫耳, 6·〇當量)後,在氮氣環境中回流下(135t:)攪拌混合物。添 加配位體(2-苯基吡啶)後立即使谈紅色懸浮液轉成黃褐 色,而當藉由加熱溶解配位體時轉成淡紅色,而攪拌後會 得到黃色懸浮液。在攪拌3小時後,在減壓下由反應混合 物蒸除溶劑,而殘留物經矽膠管柱層析純化(洗提液:二氯 甲烷/甲醇=10/1)。濃縮管柱分液後,將所得黃色固體物由 己烷/二氯曱烷再結晶而得標題化合物(114)3〇6克為黃色 粉末,產率95.8%。 46 315064 200418865 ln NMR (500MHz, CD2C12) : δ 5·8 7 (dd, J=l.l, 7·8Ηζ, 4H), 6.60 (dt, J=i.2, 7·8Ηζ, 4H), 6.79-6.85 (m, 8H), 7.56 (dd, J=1.3, 7.8Hz, 4H), 7.80 (dt, J=1.6, 7.8Hz, 4H), 7.94 (df J=7.8Hz, 4H), 1.25 (dd, J=0.8, 5.7Hz, 4H). 3ljfe 例 2 化合物(2-1〇)(雙[2-(2,4-二氟笨基)吼錠基-N,C2,]銥(III)氯 鹽二聚物)之製造 在配備有回流冷凝器之史列克氏燒瓶中置入(1,5-環 辛二烯)銥(I)氯鹽二聚物(2·〇〇克,2.98毫莫耳,1當量) 而燒瓶内部經氮氣置換。接續地添加2_乙氧基乙醇(2〇毫 升’ s/s=10)與2-(2,4-二氟苯基)吼啶(3·42克,17·88毫莫 耳’ 6·0當量)後,在氮氣環境中回流下(135它)攪拌混合 物。添加配位體(2-(2,4_二氟苯基)吼啶)後立即使淡紅色懸 子液轉成灰色,而當藉由加熱溶解配位體時轉成暗紅色, 而授掉後得到檸檬黃色懸浮液。在攪拌3小時後,在減壓 下由反應混合物蒸除溶劑,而殘留物經矽膠管桎層析純化 (洗提液·二氯曱烷/曱醇= 10/1)。濃縮管柱分液後,將所得 貝色固體物由己烷/二氯曱烷再結晶而得標題化合物 10)^.53克為黃綠色粉末,產率974 %。 47 315064 200418865 αΗ NMR(500MHzx CD2C12) : δ 5·29 (dd, >2·5, 9·1Ηζ, 4H), 6·38 (ddd, ^2·5, 9山 12·5Ηζ 4Η), 6.87 (ddd, J=1.5, 5.8, 7.2Hz, 4Η), 7.87(ddd, J=1.5, 5.8, 7·2Ηζ, 4Η), 8.33 (ddd, J=0.7, 1.5, 8.1Hz, 4Η), 9.12(ddd, J=0.7, i.5a 5.8Hzr 4H). 化合物(2-9)(雙[2_(4_甲基苯基)吼鍵基_氯鹽 一聚物)之製造 在配備有回流冷凝器之史列克氏燒瓶中置入(i,5-環 稀)銀⑴氯鹽二聚物(500毫克,0.744毫莫耳,」當量) ^燒瓶内部經氮氣置換。接續地添加2-乙氧基乙醇(5毫 耳,’ Γ〇=!^2-(4_甲基苯基)D比咬(504毫克,2·976毫莫 4·0虽®)後,在氮氣環境中回流下(135t )攪拌混合 ◎添力^位體(2_(4-甲基苯基)吼。定)後立即使淡紅色懸浮 '、褐色,而虽藉由加熱溶解配位體時轉成暗紅色, 座::後!到黃色沉澱。在攪拌3小時後,在減麼下由反 :物崧除溶劑,而殘留物經矽膠管柱層析純化(洗提 所_主乳甲w甲醇=100/1至20/〇。濃縮管柱分液後,將 于”色周體物由己烷/二氯甲烷再結晶而得標題化合物 〜)34毛克為黃色粉末。由再結晶母液,以相同方式取 奸名員外的再处曰吝4 、口日日產物60 *克。總產率:794毫克(94.6%) 〇 48 315064 200418865 化 NMR (500MHz、CD2C12) : δ 1.96 (s, 12H) , 5.66 (d, J=0.7HZ/ 4H) , 6.61 — 6.64 (ία, 4H) f 6.77 (ddd, J=1.5, 5.7, 7.4Hzf 4H) f 7.44 (df J=7.8Hz, 4H) f 7.75 (ddd, J=1.5, 7.4, 8.1Hz, 4H), 7-87 (ddd, J=0.7, 1.5, 8.1Hz, 4H), 9-19 (ddd, J=0.7, 1.5, 5,7Hz, 4H). 實施例4 化合物(2-12)(雙[2-(4-曱氧基苯基)-5v三氟甲基〇比錠基· N5C2’]銥(III)氯鹽二聚物)之製造 在配備有回流冷凝器之史列克氏燒瓶中置入(i,5-環 辛二烯)銥⑴氯鹽二聚物(200毫克,0.298毫莫耳,丨當量) 與2-(4-曱氧基苯基)-5-三氟甲基D比咬(3〇 2毫克,1192毫 莫耳,4.0當量),而燒瓶内部經氮氣置換。添加2•乙氧基 乙醇(5毫升,s/s=l〇)後,在氮氣環境中回流下(135t:)攪拌 混合物。添加配位體(2-(4-曱氧基笨基三氟曱基吡啶) 而藉由加熱溶解後所得之淡紅色懸浮液在授拌後得到亮* 色/儿瓜。在攪拌3小時後,在減壓下由反應混合物蒸除溶 劑,而殘留物經矽膠管柱層析純化(洗提液:二氯甲烷/甲 酉子-100/0至100/1)。濃縮管枉分液後,將所得橙色固體物 由己烷/二氯曱烷再結晶而得標題化合物(2_]2)394毫克為 亮黃色粉末,產率90.3 %。 ' 2H NMR(500MHzn CD2C12) : δ 49 315064 200418865 3.40 (S/ 12H), 5.22 (d, J=2.5Hz, 4H), 6.49 (dd, J=2.5, 8.6Hz, 4H) , 7.58 (d, J=8.6Hz, 4H), 7.90-7.95 (m, 8H), 9.57 (s, 4H). 實施例 5 化合物(雙(2-苯基吡錠基-N,c2’)銥(III)乙醯基丙酮鹽) 之製造 Q (1)在配備有回流冷凝器之史列克氏燒瓶中置入(1,5-環辛二烯)銥⑴氯鹽二聚物(5〇〇毫克,0.744毫莫耳,1 當量)而燒瓶内部經氮氣置換。接續地添加2 -乙氧基乙醇(5 毫升,s/s= 1〇)與2-苯基吡啶(468微升,3.274毫莫耳,4.4 當量)後,在氮氣環境中回流下(135 °C)攪拌混合物3小時。 將所得之黃色懸浮液冷卻至室溫,而後接續地將乙醯基丙 酮(2〕0微升,2.232毫莫耳,3.0當量)與碳酸鈉(237毫克, 2.232愛莫耳,3 〇當量)加至其中,而後再回流2小時而得 冗κ色%浮液。在減壓下由反應混合物蒸除溶劑,而殘留 物經矽膠管柱層析純化(洗提液:二氯曱烷)。濃縮管柱分 液後’由己燒/二氯曱烷再結晶而得標題化合物(III-i)720 毫克為免黃色粉末,產率80.7%。 50 315064 200418865 XH NMR(500MHzn CD2C12) : δ 1·79 (s, 6H), 5.23 (s,lH), 6·23 (dd, 7·3Ηζ, 2H), 6.68 (^, ^=1.3, 7.3Hz, 2H) , 6.84 (ddd, J=1.2, 7.3, 7.7Hz, 2H), 7·19 (ddd, J=1.6, 5·7, 7·5Ηζ, 2H), 7·57 (dd, J=1.3, 7·7Ηζ, 2H), 7·77 (ddd, J=1.6, 7·5, 8·2Ηζ, 2H), 7.88 {ddd, J=0.8, 1.6, 8.2Hz/2H), 8.49 (ddd, J=0.8, 1.6, 5.7Hz, 2H). (2)進行大規模之相同操作。反應使用(1,5-環辛二烯) 銥⑴氯鹽二聚物(5.00克,7.44毫莫耳,1 ·〇當量)、2-苯基 吡啶(4.7毫升,32.74毫莫耳,4·4當量)、乙醯基丙酮(2.3 毫升,22·32毫莫耳,3·〇當量)、碳酸鈉(2 37克,22·32 宅莫耳’ 3.0當量)與2 -乙氧基乙醇(50毫升,s/s = 10)作為 起始物而得標題化合物(Hi)8 〇3克,產率9〇 〇%。產物之 外型、物理性質與光譜數據皆與實施例5(丨)者相同。由於 貫施例5(1)之產率為80.7%,可知本發明之方法合適於大 規模製造。 實施例6 化合物(3-10)(雙(2-(24- - ϋ 梦 〇. 八又、V,4 一亂本基)吼錠基)銥(ΠΙ)乙 醯基丙酮鹽)之製造 ⑴在配備有回流冷凝器之史列克氏燒瓶中置入(I ,5-環辛二烯)銥(I)氯鹽二聚物(5〇〇毫克,〇 %《莫耳,工 315064 51 古、瓶内部經氮氣置換。接續地添加2-乙氧基乙醇(5 笔升 ’ s/s = i〇、^ 0 j “ ”_( 5 一二I苯基)口比啶(626毫克,3.274毫 冥耳’4.4當吾、你 jl„ ^ 士 )後’在氮氣環境中回流下(135t:)攪拌混合 才將所付之杯檬黃色懸浮液冷卻至室溫,而後接 、,賓地將乙酿基丙酮(23〇 n π j (川铽升,2·232毫莫耳,j o當量 碳酸鈉(237亳克,2 23 木^ ^ ^ ^ ^ ^ 毛矣耳,3.0當置)加至其中,而 後再回流2小時而得普色 — 卞/、巳懸汙液。在減壓下由反應混合物 :除溶劑’而殘留物經石夕膠管柱層析純化(洗提液:二氯甲 ,)/辰 '、、侣&柱分液後,由己烷/二氯曱烷再結晶而得標題 。物(3 10)8 96宅克為檸檬黃色粉末,產率78 9%。 H NMR(500MHzn CD2C12) : ζ 工肩㈨ 6Η), 5.31 (s, 1Η), 55〇 ⑽,μ」,8.贩,π), 6.38 (ddd, J=2.4, 93, κι, 2η), 7·24 (_' J=1·5, 5.7, 7.3Ηζ, 2Η), (ddt, J-^0.6, 1.6, 7.3Ηζ, 2Η) , 8.22-8.28 (m, 2Η), (ddd, >0·8, u, 5·7Ηζ, 2η)· U)進仃大規模之相同操作。反應使用(1,5-環辛二烯) 銥⑴氣鹽二聚物(5·00克,7·44毫莫耳,1〇當量)、2_(2,4一 一鼠苯基)吡啶(6.00克,32·74毫莫耳,4;2當量)、乙醯基 丙酮(2.3笔升,22.32毫莫耳,3·〇當量)、碳酸鈉(2·37克, 22.32耄莫耳,3·0當量)與2-乙氧基乙醇(50毫升,s/s = 10) 作為起始物而得標題化合物(3_1〇)8·53克為檸檬黃色粉末 為苐一產物,與純度為95·5%之黃色粉末〇·57克為第二產 物。總產率為90.5¼。產物之外型、物理性質與光譜數據 52 315064 200418865 皆與實施例6(1)者相同。 由於實施例6(1)之產率為78.9%,可知本發明之方法 合適於大規模製造。 化合物(3-9)(雙[2-(4-曱基苯基)吼錠基-N,cn銥(111)乙醯 基丙酮鹽)之製造 在配備有回流冷凝器之史列克氏燒瓶中置入(1,5-環 辛二烯)銥(I)氣鹽二聚物(5〇〇毫克,0 ·744毫莫耳,i當量) 而燒瓶内部經氮氣置換。接續地添加2-乙氧基乙醇(5毫 升’ S/S=10)與2-(t曱基苯基)口比啶(504毫克,2.976毫莫 耳’4.0當量)後,在氮氣環境中(135Ct )攪拌混合物」小時。 將所付之黃色懸浮液冷卻至室溫,而後接續地將乙醯基丙 酮(230微升,2·232毫莫耳,3.0當量)與碳酸納(237毫克, 2 2 3 2 ΐ· w 廿、 旲耳,3·0當量)加至其中,而後再攪拌3小時而得 汽 '寺島多』県、糸 '、亨、、左 心夜。在減壓下由反應混合物蒸除溶劑,而殘留 物經石夕膠;h , 、 " 往層析純化(洗提液:二氯曱烷)。濃縮管柱分 液後,由己、ρ & 、 几一^氣甲烧再結晶而得標題化合物(3 - 9) 7 3 6毫 克為黃色粉丈 。由再結晶母液以相同方法得到經再結晶之 結晶(27毫杏、+ a )之碩外的產物。總產率:763毫克(81.7%)。 315064 53 200418865 XH NMR(500MHzn CD2C12) : δ 1·78 (s, 6H), 2.06 (s, 6H), 5·26 (s, 1H), 6·04 (s, 2H), 6·67 (d, J=7.9Hz, 2H), 7.14 (ddd, 5·8, 7.2Hz, 2H), 7·46 (d, J=7.9Hz, 2H), 7·74 (ddd, J=1.6, 7·2, 8·3Η2, 2H), 7·82 (ddd, J=0.8, 1·6, 8·3Ηζ, 2H), 8.45 (ddd, J=0.8, 1.6, 5.8Hz, 2H), 實施例8 化合物(3-11 )(雙[2-(4-甲氧基苯基)-5-三氟曱基吡錠基-N,C2’]銥(III)乙醯基丙酮鹽)之製造 在配備有回流冷凝器之史列克氏燒瓶中置入(1,5·環 辛二烯)銥⑴氯鹽二聚物(500毫克,0.744毫莫耳,1當量) 與2-(4-曱氧基苯基)_5_三氟曱基吡啶(754毫克,2.976毫 莫耳’ 4.0當量),而燒瓶内部經氮氣置換。添加2_乙氧基 乙S子(5 ^:升,s/s=i〇)後,在氮氣環境中回流下(135。〇)攪拌 混合物 接續地 與碳酸 而後再 物蒸除 曱烷)。 烷再結 結晶母 的產物 小時。將所得之枯黃色懸浮液冷卻至室 將乙醯基丙酮(23〇微升,2·232毫莫耳,3〇當量) 鈉(237毫克,2.232毫莫耳,3〇當量)加至其中, 搜拌3小時而得橙色懸浮液。在減壓下由反應混合 溶劑,而殘留物經矽膠管柱層析純化(洗提液:二氯 濃縮管柱分液後,將所得橙色固體由己烷/二氯甲 晶而得標題化合物(3-11)920毫克為燈色粉末。由再 液以相同方法得到經再結晶之結晶⑽毫克)之額外 總產率:9 8 0笔克(8 2 · 8 %)。 315064 54 200418865 1H NMR(500MHzn CD2C12) : δ 1.82 (s, 6H) , 3.54 (s, 6H) , 5.33 (s, 1H) , 5.71 (d, J=2.5Hz, 2H), 6·51 (dd, J=2.5, 8·7Ηζ, 2H), 7·60 (d, J=8.7Hz, 2H), 8.67 (d, J==2.2Hz, 2H). 實施例9 化合物(3-7)(雙[2-(2,-苯并噻吩基)卩比錠基-N,C3’]銥(HI)乙 酉&基丙酮鹽)之製造 (1)在配備有回流冷凝器之史列克氏燒瓶中置入(1,5- 壤辛二稀)银(1)氣鹽二聚物(500毫克,0.744毫莫耳,1 田里)與2-(2、笨并噻吩基)吼咬(629毫克,2.976毫莫耳, 4·〇當量),而燒瓶内部經氮氣置換。添加2_乙氧基乙醇(5 彳| 毛,s/s==10)後,在氮氣環境中回流下(135°C )攪拌混合 物添加溶劑,而將所得之淡紅色懸浮液加熱至轉成暗紅 、 液而攪拌後得淡紅棕色沉澱。將所得之朱紅色懸浮 液二卹至室溫,而後接續地將乙醯基丙酮(23〇微升,2·232 '耳3·〇 §置)與碳酸鈉(237毫克,2.232毫莫耳,3 〇 其中,而後爾3小時。在減壓下由嫩 曱于、❿殘留物經石夕膠管柱層析純化(洗提液··二氯 、兀)。>辰縮管柱分液後,將所得 ^ $ Τ /人、,工木下色固體由己烷/二 " 凡再、、Ό晶而得標題化合物(3-7)743古i & a 禾,產率70.】%。 315064 55 200418865 NMR(500MHzn CD2C12) : § 1-81 (s, 6H), 5.35 (s, 1H), 6.18 (d, ^8.2Ηζ, 2H), 6.83 (ddd,㈤山 7.2, 8.2HZ, 2H), 7〇5_7ii ㈨ 4h), 7.62-7.68 (m, 4H), 7.82 (ddd, J=1.5, 7.5, 8.1Hz, 2H), 8-45 (ddd, J=0-8, i.5/ 5.7Hz, 2H). (2)進行大規杈之相同操作。反應使用(i,5-環辛二烯) 銥(I)氯鹽二聚物(3.29克,4.90毫莫耳,1〇當量)、2_(2,_ 笨并噻吩基)吡啶(4·35克,2〇.59毫莫耳,42當量)、乙酸 土丙酮(1.5先升,14.70耄莫耳,3.0當量)、碳酸鈉(156 克14.70笔莫耳,3·〇當量)與2_乙氧基乙醇⑴毫升,仏=⑺) 作為起始物而得標題化合物(3_7)5·23克為淡紅棕色粉末 第-產物,與額外的淡紅棕色粉末〇17克為第二產物。總 產率為77.4%。產物之外型、物理性質與光譜數據皆與實 施例9 (1)者相同。 由於實施例9(1)之產率| 70.1%,可知本發明之方法 合適於大規模製造。 實施例10Then ^ Λ it ^ A in a suitable solvent or " ,, & suitable solvent, and in the presence of a base, if necessary, and in the environment of lice, the obtained trivalent six buds represented by formula (II) are _ Gold 'iridium dinuclear complexes react with the compound represented by formula (VI) to obtain 43 315064 200418865 to trivalent hexabud n-metallated iridium complexes represented by formula (V). Iri :: In the step, the trivalent hexabud positive-metallized rhenium nucleus II shown in the formula (i) is subjected to the aforementioned post-treatment, isolation, and purification, and (VI) the AC is shown to react from the °. "And in this method, it is suitable to feed the trivalent hexabud orthometallized plutonium-4-'' tank into the ~ ^ complex without any post-processing, etc., followed by a single (ie, the compound shown and the compound The silver salt to the reaction tank is reacted in the early cell reaction.) The reaction silver salt includes gy, such as silver nitrate, silver acetate, and silver trifluoroarsonate. Then, the compound is first reacted with the compound represented by formula (VI). "In the reaction, and then add the compound represented by formula (VI) and continue gas silver acetate, silver pyroxanthate, and silver trifluoroacetate or trifluoromethane stone relative to formula 1 to 20 equivalents f For the compounds shown above, the general usable amount of silver salt is i equivalent, preferably i · 5 to M equivalent, and more preferably 2 to 3 In this reaction, 1 as n is mainly 6 equivalent. In this method Φ. The reaction is preferably in the range of, for example, nitrogen, argon, etc., with respect to the amount of the monovalent 铉 dinuclear complex shown in formula ⑴: the amount of the compound is appropriately selected from 4 to 100 equivalents. In addition, it is preferably 6 to 40 equivalents' and more preferably 8 to 12; it is represented by formula (VI) with respect to formula (1). When the compound is added again after the silver salt is added, the amount is suitable: for the compound, the compound represented by formula (VI) is generally free and preferably 2 to 50 equivalents, preferably 3 to 5). When I, the purity is 315 (54 44 200418865). The reaction can also be performed in combination with an ultrasonic generator. In this method, a solvent is suitable. As for the solvent, it can be used as shown in Figure 1. No. The reaction temperature is generally selected from the temperature range M to 300 ° C, preferably from 60t: to 200t, and more preferably from 8 ° to u ° C. The reaction time is generally selected from 10 minutes The range is from 72 to 72 hours, preferably from ^ minutes to 48 hours, and more preferably from i hours to 6 hours. Then, the obtained trivalent hexabud n-_metallized iridium complex represented by the formula (V) is obtained. The post-treatment, isolation, and purification as described in the schematic diagram i are performed to provide a linko substance. The method of the present invention is characterized by using a monovalent iridium dinuclear complex. Therefore, formula (Π), ⑽), (IV) or ⑺ So the trivalent six-bud positive _ metallized epi-complex can produce a high cross rate, and may not be in the material. II) Trivalent hexabud ortho-metallized dinuclear complex complex intermediates to produce these complexes. The method of the present invention is characterized by the following.) The Xibu step can be reacted in the same reaction tank and the same solvent 2) No complicated operations such as solvent recovery, post-treatment, isolation, and purification are generally required after the synthesis of intermediates.) The physical loss of intermediates caused by what is known in 2) can be minimized. 4 ) For reasons ⑽3), the cost of intermediates and final products can be reduced. The trivalent hexabud n-metal silver complex produced by the method in April is used as a phosphor. 315064 45 200418865 (Example) This The following examples will be described in more detail without intending to limit the present invention. In each case, the volume ratio of the S / S surface solvent to the initial monovalent iridium dinuclear complex weight i is expressed in units of ml / g. φExample 1 Manufacture of bis (IIm) (bis (2-benzylpyridinyl-N, C2,) iridium chloride dimer) was prepared at Schlenk's, equipped with a reflux condenser. ) (1,5-octadiene) iridium osmium chloride dimer (2.0 g, 2% millimolar, 1 s) was placed in the flask, and the inside of the flask was replaced with nitrogen. After successively adding 2-ethoxyethanol (20 ml, s / s: = 10) and 2-phenylpyridine (2.56 ml, ΐ7.88 mmol, 6.0 equivalents), the mixture was placed in a nitrogen atmosphere. The mixture was stirred at reflux (135t :). Immediately after adding the ligand (2-phenylpyridine), the red suspension was turned to yellow-brown, and when the ligand was dissolved by heating, it turned to reddish, and a yellow suspension was obtained after stirring. After stirring for 3 hours, the solvent was distilled off from the reaction mixture under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: dichloromethane / methanol = 10/1). After liquid separation on a concentrating column, the obtained yellow solid was recrystallized from hexane / dichloromethane to obtain the title compound (114), 3.06 g, as a yellow powder, with a yield of 95.8%. 46 315064 200418865 ln NMR (500MHz, CD2C12): δ 5 · 8 7 (dd, J = ll, 7 · 8Ηζ, 4H), 6.60 (dt, J = i.2, 7 · 8Ηζ, 4H), 6.79-6.85 (m, 8H), 7.56 (dd, J = 1.3, 7.8Hz, 4H), 7.80 (dt, J = 1.6, 7.8Hz, 4H), 7.94 (df J = 7.8Hz, 4H), 1.25 (dd, J = 0.8, 5.7Hz, 4H). 3ljfe Example 2 Compound (2-1〇) (bis [2- (2,4-difluorobenzyl) pyridinyl-N, C2,] iridium (III) chloride salt di Manufacture of (polymer) In a Schleich flask equipped with a reflux condenser, (1,5-cyclooctadiene) iridium (I) chloride salt dimer (2.0 g, 2.98 mmol) , 1 equivalent) and the inside of the flask was replaced with nitrogen. Successively add 2-ethoxyethanol (20 ml's / s = 10) and 2- (2,4-difluorophenyl) anhydropyridine (3.42 g, 17.88 millimoles' 6 · After 0 eq.), The mixture was stirred under reflux (135 it) under a nitrogen atmosphere. Immediately after adding the ligand (2- (2,4_difluorophenyl) cyclopyridine), the pale red suspension turned gray, and when the ligand was dissolved by heating, it turned dark red. A lemon yellow suspension was obtained. After stirring for 3 hours, the solvent was distilled off from the reaction mixture under reduced pressure, and the residue was purified by silica gel tube chromatography (eluent · dichloromethane / methanol = 10/1). After liquid separation on a concentrating column, the obtained shell-colored solid was recrystallized from hexane / dichloromethane to obtain the title compound 10) ^. 53 g as a yellow-green powder with a yield of 974%. 47 315064 200418865 αΗ NMR (500MHzx CD2C12): δ 5.29 (dd, > 2.5, 9 · 1Ηζ, 4H), 6.38 (ddd, ^ 2 · 5, 9 山 12 · 5Ηζ 4Η), 6.87 (ddd, J = 1.5, 5.8, 7.2Hz, 4Η), 7.87 (ddd, J = 1.5, 5.8, 7.2Ηζ, 4Η), 8.33 (ddd, J = 0.7, 1.5, 8.1Hz, 4Η), 9.12 ( ddd, J = 0.7, i.5a 5.8Hzr 4H). The compound (2-9) (bis [2_ (4_methylphenyl) hexyl group_chloride monopolymer) is manufactured on a reflux condenser A Schleich flask was charged with (i, 5-cyclodiluted) silver sulfonium chloride dimer (500 mg, 0.744 mmol, "equivalent). ^ The inside of the flask was replaced with nitrogen. After successively adding 2-ethoxyethanol (5 mmol, 'Γ〇 =! ^ 2- (4-methylphenyl) D specific bite (504 mg, 2 · 976 mmol 4.0 · ®), Stir and mix under reflux (135t) in a nitrogen environment. ◎ Add the ^ site (2- (4-methylphenyl) Hou. Fixed) immediately after the light red suspended ', brown, although the ligand is dissolved by heating Turn to dark red, Block :: After! To a yellow precipitate. After stirring for 3 hours, remove the solvent from the anti: substance under reduced pressure, and the residue is purified by silica gel column chromatography (washing station_main milk Mw methanol = 100/1 to 20 / 〇. After liquid separation in the concentration column, the color compound was recrystallized from hexane / dichloromethane to obtain the title compound ~) 34 g was yellow powder. Recrystallized The mother liquor was taken in the same way and reprocessed outside the celebrity, and the daily product was 60 * g. Total yield: 794 mg (94.6%) 〇48 315064 200418865 Chemical NMR (500MHz, CD2C12): δ 1.96 (s , 12H), 5.66 (d, J = 0.7HZ / 4H), 6.61 — 6.64 (ία, 4H) f 6.77 (ddd, J = 1.5, 5.7, 7.4Hzf 4H) f 7.44 (df J = 7.8Hz, 4H) f 7.75 (ddd, J = 1.5, 7.4, 8.1Hz, 4H), 7-87 (ddd, J = 0.7, 1.5 , 8.1Hz, 4H), 9-19 (ddd, J = 0.7, 1.5, 5,7Hz, 4H). Example 4 Compound (2-12) (bis [2- (4-methoxyoxyphenyl)- Manufacture of 5v trifluoromethyl 0-based ingot base · N5C2 '] iridium (III) chloride salt dimer) Put in (i, 5-cyclooctadiene) in a Schleich flask equipped with a reflux condenser Iridium phosphonium chloride dimer (200 mg, 0.298 mmol, equivalent) and 2- (4-fluorenylphenyl) -5-trifluoromethyl D specific bite (302 mg, 1192 mmol) Ear, 4.0 equivalents), and the inside of the flask was replaced with nitrogen. After adding 2 • ethoxyethanol (5 ml, s / s = 10), the mixture was stirred under reflux (135 t :) under a nitrogen atmosphere. The ligand was added (2- (4-Methoxybenzyltrifluoropyridylpyridine)) and the pale red suspension obtained after dissolving by heating gives a bright * color / melon after mixing. After stirring for 3 hours, the pressure is reduced. The solvent was distilled off from the reaction mixture, and the residue was purified by silica gel column chromatography (eluent: dichloromethane / formamidine -100/0 to 100/1). After concentrating the tube, the resulting orange was separated The solid was recrystallized from hexane / dichloromethane to give the title compound (2_) 2) 394 mg Bright yellow powder, yield 90.3%. 2H NMR (500MHzn CD2C12): δ 49 315064 200418865 3.40 (S / 12H), 5.22 (d, J = 2.5Hz, 4H), 6.49 (dd, J = 2.5, 8.6Hz , 4H), 7.58 (d, J = 8.6Hz, 4H), 7.90-7.95 (m, 8H), 9.57 (s, 4H). Example 5 Compound (bis (2-phenylpyridinyl-N, c2 ') Manufacturing of iridium (III) acetamidinium acetone salt) Q (1) Put a (1,5-cyclooctadiene) iridium phosphonium chloride dimer in a Schleich flask equipped with a reflux condenser (500 mg, 0.744 mmol, 1 equivalent) and the inside of the flask was replaced with nitrogen. After successively adding 2-ethoxyethanol (5 ml, s / s = 10) and 2-phenylpyridine (468 µl, 3.274 mmol, 4.4 equivalents), the mixture was refluxed under a nitrogen atmosphere (135 ° C) The mixture was stirred for 3 hours. The resulting yellow suspension was cooled to room temperature, and then acetone (2) 0 µl, 2.232 mmol, 3.0 eq.) And sodium carbonate (237 mg, 2.232 emoll, 30 eq.) Were successively added. It was added thereto, and then refluxed for another 2 hours to obtain a redundant kappa color% floater. The solvent was distilled off from the reaction mixture under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: dichloromethane). After liquid separation in a concentrating column, 720 mg of the title compound (III-i) was obtained as recrystallized from hexane / dichloromethane, and the yield was 80.7%. 50 315064 200418865 XH NMR (500MHzn CD2C12): δ 1 · 79 (s, 6H), 5.23 (s, lH), 6.23 (dd, 7 · 3Ηζ, 2H), 6.68 (^, ^ = 1.3, 7.3Hz , 2H), 6.84 (ddd, J = 1.2, 7.3, 7.7Hz, 2H), 7.19 (ddd, J = 1.6, 5 · 7, 7 · 5Ηζ, 2H), 7.57 (dd, J = 1.3 , 7 · 7Ηζ, 2H), 7.77 (ddd, J = 1.6, 7 · 5, 8 · 2Ηζ, 2H), 7.88 (ddd, J = 0.8, 1.6, 8.2Hz / 2H), 8.49 (ddd, J = 0.8, 1.6, 5.7Hz, 2H). (2) Perform the same operation on a large scale. The reaction used (1,5-cyclooctadiene) iridium osmium chloride salt dimer (5.00 g, 7.44 mmol, 1.0 equivalent), 2-phenylpyridine (4.7 ml, 32.74 mmol, 4 · 4 equivalents), acetoacetone (2.3 ml, 22.32 millimoles, 3.0 equivalents), sodium carbonate (2 37 grams, 22.32 house mole '3.0 equivalents), and 2-ethoxyethanol ( 50 ml, s / s = 10) was used as a starting material to obtain 803 g of the title compound (Hi) in a yield of 900%. The appearance, physical properties and spectral data of the product were the same as those in Example 5 (丨). Since the yield of Example 5 (1) is 80.7%, it can be seen that the method of the present invention is suitable for large-scale production. Example 6 Production of Compound (3-10) (Bis (2- (24--ϋ Dream 0.8, V, 4 Yiranbenzyl) stilbenyl) Iridium (ΠΙ) Ethyl acetone salt) A Schleich flask equipped with a reflux condenser was charged with (I, 5-cyclooctadiene) iridium (I) chloride salt dimer (500 mg, 0% "Mole, Gong 315064 51 Gu 2. The inside of the bottle was replaced with nitrogen. 2-Ethoxyethanol (5 strokes's / s = i0, ^ 0 j "" _ (5-diphenyl) phenyl) (626 mg, 3.274) Milli-Ears' 4.4 When I, you jl ^ ^)) under a nitrogen atmosphere reflux (135t :), stir and mix before cooling the cup of lemon yellow suspension to room temperature, and then, Ethyl acetone (230 π j (Chuanxiong liter, 2.232 millimoles, jo equivalent sodium carbonate (237 g, 2 23 wood ^ ^ ^ ^ ^ ^ Mao Tang, 3.0 pang)) Among them, and then refluxed for another 2 hours to obtain the general color-卞 /, 巳 suspension liquid. The residue was purified from Shixi gel column chromatography under reduced pressure (eluent: dichloromethane). ,) / 辰 '、, couple & column The title was recrystallized from alkane / dichloromethane. The product (3 10) 8 96 g was a lemon yellow powder with a yield of 97.9%. H NMR (500MHzn CD2C12): ζ Worker Shoulder 6Η), 5.31 (s, 1Η), 55〇⑽, μ ″, 8., π), 6.38 (ddd, J = 2.4, 93, κι, 2η), 7 · 24 (_ 'J = 1 · 5, 5.7, 7.3Ηζ, 2Η ), (ddt, J- ^ 0.6, 1.6, 7.3Ηζ, 2Η), 8.22-8.28 (m, 2Η), (ddd, > 0 · 8, u, 5. · 7Ηζ, 2η) · U) The scale is the same. The reaction uses (1,5-cyclooctadiene) iridium osmium gas salt dimer (5.0 g, 7.44 millimoles, 10 equivalents), 2_ (2,4 one mouse Phenyl) pyridine (6.00 grams, 32.74 millimoles, 4; 2 equivalents), acetamidine (2.3 pen liters, 22.32 millimoles, 3.0 equivalents), sodium carbonate (2.37 grams, 22.32耄 Mor, 3.0 equivalents) and 2-ethoxyethanol (50 ml, s / s = 10) as starting materials to obtain the title compound (3_1〇) 8.53 g as a lemon yellow powder as the first product And 0.57 g of yellow powder with a purity of 95.5% is the second product. The total yield is 90.5¼. The product's appearance, physical properties and spectral data are 52 315064 200418865, which are all the same as in Example 6 (1). Same. Since Example 6 (1) The yield was 78.9%, the known method of the present invention suitable for large scale manufacture. Production of compound (3-9) (bis [2- (4-fluorenylphenyl) sulfonyl-N, cniridium (111) acetamidinone)) in a Schleich flask equipped with a reflux condenser A (1,5-cyclooctadiene) iridium (I) gas salt dimer (500 mg, 0.744 mmol, i equivalent) was placed in the flask, and the inside of the flask was replaced with nitrogen. After successively adding 2-ethoxyethanol (5 ml 'S / S = 10) and 2- (t-methylphenyl) orbitalidine (504 mg, 2.976 mmoles' 4.0 equivalents), in a nitrogen atmosphere (135Ct) The mixture was stirred for hr. The yellow suspension was cooled to room temperature, and then ethylacetone (230 μl, 2.232 mmol, 3.0 equivalents) and sodium carbonate (237 mg, 2 2 3 2 ΐ · w 续) were successively added. , 旲 耳, 3.0 equivalents), and then stir for 3 hours to get steam "Tajimado" 県, 糸, Heng, and Zuo Xin Ye. The solvent was distilled off from the reaction mixture under reduced pressure, and the residue was purified by chromatography (h2, ") (eluent: dichloromethane). After the liquid was concentrated in the column, the title compound (3-9) 7 3 6 mg was obtained from hexane, ρ & From the recrystallization mother liquor, a recrystallized crystal (27 mmol, + a) was obtained in the same manner as the extra product. Total yield: 763 mg (81.7%). 315064 53 200418865 XH NMR (500MHzn CD2C12): δ 1.78 (s, 6H), 2.06 (s, 6H), 5.26 (s, 1H), 6.04 (s, 2H), 6.67 (d , J = 7.9Hz, 2H), 7.14 (ddd, 5 · 8, 7.2Hz, 2H), 7.46 (d, J = 7.9Hz, 2H), 7.74 (ddd, J = 1.6, 7 · 2 , 8 · 3Η2, 2H), 7.82 (ddd, J = 0.8, 1.6, 8 · 3Ηζ, 2H), 8.45 (ddd, J = 0.8, 1.6, 5.8Hz, 2H), Example 8 Compound ( 3-11) (bis [2- (4-methoxyphenyl) -5-trifluoroamidinopyridinyl-N, C2 '] iridium (III) acetamidoacetone) A Schleich flask of a condenser was charged with (1,5 · cyclooctadiene) iridium osmium chloride dimer (500 mg, 0.744 mmol, 1 equivalent) and 2- (4-fluorenoxybenzene ) -5_trifluorofluorenylpyridine (754 mg, 2.976 millimoles' 4.0 equivalents), and the inside of the flask was replaced with nitrogen. After the addition of 2-ethoxyethane (5: 1 liter, s / s = 10), the mixture was stirred under reflux (135.0) under a nitrogen atmosphere, and the mixture was successively mixed with carbonic acid, and then the oxane was distilled off. The alkane re-crystallizes the product of the mother hour. The resulting withered yellow suspension was cooled to room, and ethylacetoacetone (230 microliters, 2.232 millimoles, 30 equivalents) sodium (237 mg, 2.232 millimoles, 30 equivalents) was added thereto, Search for 3 hours to obtain an orange suspension. The solvent was mixed from the reaction under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: dichloro concentration column separation. The obtained orange solid was obtained from hexane / dichloroformite to obtain the title compound (3 -11) 920 mg is a light-colored powder. An additional total yield of recrystallized crystalline milligram (mg) obtained from the re-liquid in the same way: 980 pens (82. 8%). 315064 54 200418865 1H NMR (500MHzn CD2C12): δ 1.82 (s, 6H), 3.54 (s, 6H), 5.33 (s, 1H), 5.71 (d, J = 2.5Hz, 2H), 6.51 (dd, J = 2.5, 8 · 7Ηζ, 2H), 7.60 (d, J = 8.7Hz, 2H), 8.67 (d, J == 2.2Hz, 2H). Example 9 Compound (3-7) (double [ Manufacture of 2- (2, -benzothienyl) pyrene-N, C3 '] iridium (HI) acetamidine & acetone salt) (1) In a Schleich flask equipped with a reflux condenser Place (1,5-looxacin dilute) silver (1) gas salt dimer (500 mg, 0.744 mmol, 1 field) and 2- (2, benzothienyl) roar bite (629 mg , 2.976 millimoles, 4.0 equivalents), and the inside of the flask was replaced with nitrogen. After adding 2-ethoxyethanol (5 5 | wool, s / s == 10), the mixture was stirred under reflux (135 ° C) in a nitrogen environment to add a solvent, and the resulting pale red suspension was heated to turn into Dark red, liquid and stirred to get a reddish brown precipitate. The resulting vermilion suspension was two-folded to room temperature, and then acetoacetone (230 microliters, 2.232 ′ ears 3.0 °) and sodium carbonate (237 mg, 2.232 millimoles, 30%, and then 3 hours. The residue was purified from Shixi gel column chromatography (eluent ·· dichloro, 兀) under reduced pressure from the syringium and yttrium residues. ≫ After the column was separated for separation The obtained solid was colored hexane / di " Fan Zai, Ό " Fan Zai, Ό crystals to obtain the title compound (3-7) 743 Gu i & a, yield 70.]%. 315064 55 200418865 NMR (500MHzn CD2C12): § 1-81 (s, 6H), 5.35 (s, 1H), 6.18 (d, ^ 8.2Ηζ, 2H), 6.83 (ddd, Sheshan 7.2, 8.2HZ, 2H) , 7〇5_7ii ㈨ 4h), 7.62-7.68 (m, 4H), 7.82 (ddd, J = 1.5, 7.5, 8.1Hz, 2H), 8-45 (ddd, J = 0-8, i.5 / 5.7 Hz, 2H). (2) Perform the same operation for large scale. The reaction used (i, 5-cyclooctadiene) iridium (I) chloride salt dimer (3.29 g, 4.90 mmol, 10 equivalents), 2 (2, _ benzothienyl) pyridine (4.35 G, 20.59 millimoles, 42 equivalents), acetone acetate (1.5 liters, 14.70 millimoles, 3.0 equivalents), sodium carbonate (156 grams of 14.70 moles, 3.0 equivalents) and 2-B Oxyethanol (⑴ml, 仏 = ⑺) was used as starting material to obtain 5.23 g of the title compound (3_7) as the first product of light reddish brown powder, and 17 g of additional light reddish brown powder as the second product. The total yield was 77.4%. The product shape, physical properties and spectral data were all the same as those in Example 9 (1). Since the yield of Example 9 (1) | 70.1%, it can be seen that the method of the present invention is suitable for large-scale production. Example 10
化合物(4-2)(雙[2_(2,心二氟苯基)吼錠基_N,C 吡啶鹽)之製造 土 一在配備有回流冷凝器之史列克氏燒瓶中置入(ι,5-環 ' 辛希)銀⑴氯鹽一聚物(5〇〇毫克,0.744毫莫耳,^當量) 而燒瓶内部經氮氣置換。接▲ Ί 卜 ‘ 八乱罝谀接鉍地添加乙氧基乙醇(5毫 升’ s/s-1〇)與2_(2,4_二氟苯基)哦咬(626毫克,g w毫莫 315064 56 200418865 耳’ 4:當量’在氮氣環境中回流下(135t)攪拌混合物 3 λ! 4⑯所付之榉檬黃色懸浮液冷卻至室溫 啶鈉(324毫克,2.232毫 曰 毛異耳,3.0畜加至其中,而後 再於回流下㈣3小時。隨著反應的進行,料液緩慢地 轉成板色在減壓下由反應混合物蒸除溶劑,%殘留物經 石夕膠管柱層析純化(洗提液:二氯曱烧/甲醇=20/1)。濃縮管 柱分液後,將所得黃色固體由己烧/二氯甲烧再結晶而得標 題化合物(4-2)967毫克為檸檬黃色粉末,產率93.6%。 1H NMR(500MHzn CD2C12) : δ 5.62 (dd, J=2.4, 8.7HZ/ 1H), 5.85 (dd, J=2.4, 8.7Hz, 1H), 6.44 (ddd, j=2.4, 9.2, 12.6Hz, 1H), 6.50 (ddd, j^.4, 9.2f 12.6Hz, 1H), 7.02 (ddd, 5.9f 7.4Hz, 1H), 7.21 (ddd, j=i.5, 5.9/ 7·4Ηζ, iH), 7.40 (ddd, 5.4, 7.6Hz,lH), 7.46 (ddd, J=〇.8, 1.6, 5.9Hz, 1H) , 7.75-7.86 (in, 3H) , 7.94 (dt, J=1.5, 7.6Hz; 1H), 8.20-8.28 (ΙΠΛ2Η), 8.28-8.37 (πι, 1H), 8.69 (ddd, J=〇.7, 1.6f 5.9Hzf 1H). 實施例1 1 化合物(Vm)(參(2_苯基吡錠基_N,C2:)銥(m))之製造 在配備有回流冷凝器之史列克氏燒瓶中置入(1,5-環 辛一稀)鈒⑴氣鹽二聚物(500毫克,0.744毫莫耳,]當量) 57 315064 200418865 而燒瓶内部經氮氣置換。接續地添加2-乙氧基乙醇(5毫 升,s/S=l〇)與2-苯基吡啶(46s微升,3·274毫莫耳,4.4 當置)後’在氮氣環境中回流下(1 3 5。(:)攪拌混合物3小時。 將所得之黃色懸浮液冷卻至室溫,將三氟甲烷磺酸銀 (1)(573毫克,2,232毫莫耳,3·〇當量)加至其中,而後再 於室溫下攪拌1 〇分鐘而得暗棕色懸浮液。添加額外量之2_ 乙氧基乙醇(7毫升,s/s= 14)後以滴入方式添加2-苯基吡啶 (638微升,4.464毫莫耳,6.0當量),而後再於回流下攪 拌混合物3小時而得黃褐色懸浮液。在減壓下由反應混合 物蒸除溶劑,而殘留物經矽膠管柱層析純化(洗提液:二氯 甲烧)。濃縮管柱分液後,將所得黃色固體由己烷/二氯甲 烧再結晶而得標題化合物(V_i)837毫克為黃色粉末,產率 8 5.9%。 αΗ NMR(50 0MHzn CD2C12) : δ 6.72-6.81 (m/ 6H) , 6.85-6.93 (m, 6H), 7.56 (ddd, J=〇.8, 1.6, 5.5Hz, 3H), 7.62-7.69 (m, 6H), 7.89-7·94 (m, 3H). 實施例1 2 化合物^乂八參^乙肛二氟苯基州錠基以工^銥⑴…之 製造 在配備有回流冷凝器之史列克氏燒瓶中置入(1,5_環 辛二烯)银⑴氣鹽二聚物(500毫克,0.744毫莫耳,1當量) 而燒瓶内部經氮氣置換。接續地添加2-乙氧基乙醇(5毫 58 315064 200418865 升,s/s = l〇)與2_(2,4_二氟苯基)吡啶(626毫克,3274毫莫 耳’ 4·4當量)後’在氮氣環境中回流下(135。〇授掉混合物 3小%。將所得之黃綠色懸浮液冷卻至室溫,將三氟甲烷 磺酸銀(1)(573毫克,2 232毫莫耳,3 〇當量)加至其中, 而後再於回流下授拌1G分鐘而得暗棕色懸浮液,而產生棕 色沉澱。添加額外量之2_乙氧基乙醇(8·5毫升,s/s=i7)後 以滴入方式添力口 2_(2,4•二敦苯基)卩比咬(853毫克,4 毫 ^耳’ 6.0 一當量)’而後再於回流下授掉混合物3小時而得 κ褐色心汗液。在減壓下由反應混合物蒸除溶劑,而殘留 物經石夕膠管柱層析純化(洗提液:二氯甲院)。濃縮管柱分 液後,將所得黃綠色固體由己烧/二氯甲烧再結晶而得標題 化合物(5-6)983毫克為黃綠色粉末,產率866%。Manufacture of compound (4-2) (bis [2_ (2, cardiodifluorophenyl) pyridinyl_N, C pyridine salt)-Place in a Schleich flask equipped with a reflux condenser (ι , 5-Cyclo'sin) silver phosphonium chloride monopolymer (500 mg, 0.744 mmol, ^ equivalent) and the inside of the flask was replaced with nitrogen. ▲ Ί Ί 卜 '' Bu '罝 谀 罝 谀 Add ethoxy ethanol (5 ml' s / s-1〇) and 2_ (2,4_difluorophenyl) Oh bite (626 mg, gw imo 315064) 56 200418865 Ear '4: Equivalent' Stir the mixture under reflux (135t) in a nitrogen atmosphere 3 λ! 4 The beech lemon yellow suspension was cooled to room temperature sodium pyridinium (324 mg, 2.232 millimoles, 3.0 animal) Add to it, and then simmer for 3 hours under reflux. With the progress of the reaction, the feed liquid slowly turns to a plate color. The solvent is distilled off from the reaction mixture under reduced pressure, and the residue is purified by Shixi gel column chromatography (washing Extraction solution: dichloromethane / methanol = 20/1). After liquid separation in a concentrated column, the obtained yellow solid was recrystallized from hexane / methylene chloride to obtain 967 mg of the title compound (4-2) as a lemon yellow powder. Yield, 93.6%. 1H NMR (500MHzn CD2C12): δ 5.62 (dd, J = 2.4, 8.7HZ / 1H), 5.85 (dd, J = 2.4, 8.7Hz, 1H), 6.44 (ddd, j = 2.4, 9.2, 12.6Hz, 1H), 6.50 (ddd, j ^ .4, 9.2f 12.6Hz, 1H), 7.02 (ddd, 5.9f 7.4Hz, 1H), 7.21 (ddd, j = i.5, 5.9 / 7 4Ηζ, iH), 7.40 (ddd, 5.4, 7.6Hz, lH), 7.46 (ddd, J = 0.8, 1.6, 5.9 Hz, 1H), 7.75-7.86 (in, 3H), 7.94 (dt, J = 1.5, 7.6Hz; 1H), 8.20-8.28 (ΙΠΛ2Η), 8.28-8.37 (πι, 1H), 8.69 (ddd, J = 〇.7, 1.6f 5.9Hzf 1H). Example 1 1 Compound (Vm) (see (2-phenylpyridinyl_N, C2 :) iridium (m)) is manufactured in the history of equipped with reflux condenser (1,5-cyclooctane-diluted) tritium salt dimer (500 mg, 0.744 mmol,] equivalent) was placed in a Lek flask, and the inside of the flask was replaced with nitrogen. Add 2 successively -After ethoxyethanol (5 ml, s / S = 10) and 2-phenylpyridine (46 s microliter, 3.274 millimoles, 4.4 when placed) 'under reflux under nitrogen (1 3 5 (:) The mixture was stirred for 3 hours. The resulting yellow suspension was cooled to room temperature, and silver (1) trifluoromethanesulfonate (573 mg, 2,232 mmol, 3.0 equivalents) was added thereto, and then again Stir at room temperature for 10 minutes to obtain a dark brown suspension. Add an additional amount of 2_ ethoxyethanol (7 mL, s / s = 14), add 2-phenylpyridine (638 μl, 4.464 mmol, 6.0 equivalents) dropwise, and stir under reflux The mixture was allowed to stand for 3 hours to give a tan suspension. The solvent was distilled off from the reaction mixture under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: dichloromethane). After the liquid was concentrated on the column, the obtained yellow solid was recrystallized from hexane / dichloromethane to obtain 837 mg of the title compound (V_i) as a yellow powder with a yield of 8 5.9%. αΗ NMR (50 0MHzn CD2C12): δ 6.72-6.81 (m / 6H), 6.85-6.93 (m, 6H), 7.56 (ddd, J = 0.8, 1.6, 5.5Hz, 3H), 7.62-7.69 (m , 6H), 7.89-7 · 94 (m, 3H). Example 1 2 The compound ^ 乂 参 参 ^ ethyl anion difluorophenyl sulfonium base based on the process ^ iridium ⑴… in the history of equipped with a reflux condenser A Lek flask was charged with (1,5-cyclooctadiene) silver hafnium dimer (500 mg, 0.744 mmol, 1 equivalent), and the inside of the flask was replaced with nitrogen. Successively add 2-ethoxyethanol (5 mmol 58 315064 2004 18865 liters, s / s = 10) and 2_ (2,4_difluorophenyl) pyridine (626 mg, 3274 mmoles' 4 · 4 equivalents ) 'Under reflux in a nitrogen environment (135. 0 3% of the mixture was decanted. The resulting yellow-green suspension was cooled to room temperature, and silver (1) trifluoromethanesulfonate (573 mg, 2 232 mmol) Ear, 30 equivalents) was added to it, and then agitated under reflux for 1G minutes to obtain a dark brown suspension, resulting in a brown precipitate. An additional amount of 2-ethoxyethanol (8.5 ml, s / s) was added. = i7), and then add 2_ (2,4 • diphenyl) to the bite ratio (853 mg, 4 milli-ears '6.0 one equivalent)' by dripping, and then administer the mixture under reflux for 3 hours. Kappa brown heart sweat was obtained. The solvent was distilled off from the reaction mixture under reduced pressure, and the residue was purified by Shixi gel column chromatography (eluent: dichloromethane). After the concentration of the column, the resulting solution was yellow-green The solid was recrystallized from hexane / methylene chloride to obtain 983 mg of the title compound (5-6) as a yellow-green powder with a yield of 866%.
aH NMR(50〇MHzn CD2C12) : δ 6.23 (dd, c: Q • ^ 9.2Hz, 3H), 6.41 (ddd, J=2.5/ 9.2, 13.1Hz, 3H), 6.97 (ddd, α,!.3/ 5.6, 7.2Hz, 3H), 7·5〇 (ddd,㈣·8, u, 5·6Ηζ, 3h), 7·7〇-m (m, 3h), m34 (m, 3h)· 實施例1 3 氧基笨基)吼錠基cr]银(In))· 化合物(5-7)(參[2-(‘ 製造 在配備有回流冷凝器之史列克氏燒瓶中置入(1,5· 辛一烯)银⑴氯鹽—聚物(2⑼毫克,Ο·]%毫莫耳,1杳j 3 J 5064 59 200418865 與2-(4-曱氧基苯基)吼啶(222毫克,1311毫莫耳,4·4當 量),而燒瓶内部經氮氣置換。添加2_乙氧基乙醇(2毫升, s/s=l〇)後,在氮氣環境中回流下(135。〇攪拌混合物3小 時。將所得之黃色懸浮液冷卻至室溫,將三氟甲烷磺酸銀 (1)(230毫克,0.894毫莫耳,3·〇當量)加至其中,而後再 於回流下攪拌1 0分鐘而得棕色沈澱。添加額外量之2 _乙 氧基乙醇(2毫升,s/s=10)後添加2-(心甲氧基笨基)吼啶 (252毫克,1490毫莫耳,5.〇當量),而後再於回流下攪 拌混合物3小時。在減壓下由反應混合物蒸除溶劑,而殘 留物經矽膠管柱層析純化(洗提液:二氯甲烷)。濃縮管柱 分液後,將所得檸檬黃色固體由己烷/二氯甲烷再結晶而得 標題化合物(5-7)3 16毫克為黃綠色粉末,產率761%。 2H NMR(500HHzn CD2C12) : δ 3.55 (s, 9H)/ 6.31 (d, J=2.7HZ/ 3H) , 6.46 (dd, j=2/7, 8.6Hz, 3H), 6.83 (ddd, J=1.3, 5.6, 7.2Hz, 3H)f 7.58 (ddd, J=1.6, 7.2, 8.3Hz,3H), 7·60 (d, J=8.6Hz, 3H), 7-78 (ddd, J=0.8, 1·3, 8·3Ηζ, 3H)· 實施例14 化合物(v-i)(參(2:苯基吡錠基_N,c2,)銥(III))之兩步驟製造 在史列克氏燒瓶中置入實施例1中製造之化合物(π_ i)(雙(2-苯基吡錠基·N,Cr)銥(ΙΙΙ)氣鹽二聚物)(2〇〇毫 克,0.187毫莫耳,1當量)與三氟曱烷磺酸銀⑴(144毫 315064 60 200418865 克,0·561毫莫耳,3.0當量),而燒瓶内部經氮氣置換。添 加2 -乙氧基乙酵(1宅升’ s/s = 5)與2 -苯基D比咬(163微升 1 · 1 2 2宅莫耳,6 · 0當量)後,在回流下(13 5 °C )搜拌混合物3 小時。濃縮所得之黃褐色懸浮液,而殘留物經石夕谬管柱層 析純化(洗提液:二氯曱;):完)。濃縮管柱分液後,由己燒/二 氯曱烧再結晶而得標題化合物(V - i) 2 0 8毫克為黃色粉末, 產率83.4¾。產物之NMR數據相同於實施例11。 由實施例1之總產率為79.9%。當在單槽中進行此步 驟時,實施例11之總產率為85.9%(參照實施例n)。顯示 本發明之方法較有利地係在單槽中進行。 比較實施例1 根據敘述於wo 02/02714(專利文# 1)之方法製造化合物 (5-6)(參[2-(2,4_二氟苯基殘錠基_n,c6,]銀⑴⑴ 社文外兄氏燒瓶中置 一、…二軋;宅見, 1·42毫莫耳,1當量)盥 厂、二鼠甲烷磺酸銀(1)(1.09克,4.26 毫莫耳,3 · 0當量),而植紅 而&瓶内部經氮氣置換。添加2-(2,心 —鼠本基)口比口定(2臺斗 / 〇Λ。 毛升’ S/S==4)與水(1毫升,s/s = 2)後’在 200 C油浴中加熱混合物 #八 物而祝拌3小時。將所得黑色混合物 洛發至乾,而殘留物么 ^^ 斤 、二夕取g桎層析純化(洗提液:二氯曱 緃)。濃縮管柱分液後, 外人仏/c 田己垸/二氯曱烷再結晶而得標題 化合物(5-6)5 71毫克 ^ NMP ^ ”、、H 4色粉末,產率52.7%。產物之 NMR數據相同於實施例12。 315064 61 200418865 根據本發明之方法,能有效地在傳統方式中提供多種 之三價六芽正-金屬化銥錯合物,而該等錯合物有用於作為 光激發元件之材料。 62 315064aH NMR (50 MHz MHz CD2C12): δ 6.23 (dd, c: Q • ^ 9.2Hz, 3H), 6.41 (ddd, J = 2.5 / 9.2, 13.1Hz, 3H), 6.97 (ddd, α,! .3 / 5.6, 7.2Hz, 3H), 7.50 (ddd, ㈣8, u, 5.6Ηζ, 3h), 7.70-m (m, 3h), m34 (m, 3h) 1 3 oxybenzyl) stilbyl cr] silver (In)) · compound (5-7) (see [2- ('manufactured in a Schleich flask equipped with a reflux condenser, (1, 5. · octadiene) silver phosphonium chloride salt-polymer (2 mg, 0 ·]% millimolar, 1 杳 j 3 J 5064 59 200418865 and 2- (4-methoxyphenyl) hexidine (222 mg , 1311 millimoles, 4.4 equivalents), and the inside of the flask was replaced with nitrogen. After adding 2-ethoxyethanol (2 ml, s / s = 10), the mixture was refluxed under a nitrogen atmosphere (135.0 stirring). The mixture was allowed to cool for 3 hours. The resulting yellow suspension was cooled to room temperature, and silver (1) trifluoromethanesulfonate (230 mg, 0.894 mmol, 3.0 equivalents) was added thereto, followed by stirring under reflux for 1 hour. A brown precipitate was obtained in 0 minutes. An additional amount of 2-ethoxyethanol (2 ml, s / s = 10) was added followed by 2- (cardimethoxymethoxybenzyl) pyridine (252 mg, 1490 mmol). Ear, 5.0 equivalent), and then the mixture was stirred under reflux for 3 hours. The solvent was distilled off from the reaction mixture under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: dichloromethane). Concentrated After column separation, the obtained lemon yellow solid was recrystallized from hexane / dichloromethane to obtain the title compound (5-7) 3. 16 mg was a yellow-green powder with a yield of 761%. 2H NMR (500HHzn CD2C12): δ 3.55 (s, 9H) / 6.31 (d, J = 2.7HZ / 3H), 6.46 (dd, j = 2/7, 8.6Hz, 3H), 6.83 (ddd, J = 1.3, 5.6, 7.2Hz, 3H) f 7.58 (ddd, J = 1.6, 7.2, 8.3Hz, 3H), 7.60 (d, J = 8.6Hz, 3H), 7-78 (ddd, J = 0.8, 1.3, 8.3 · ζ, 3H) · Example 14 Two-step production of compound (vi) (refer to (2: phenylpyridinyl_N, c2,) iridium (III)) Put the compound produced in Example 1 in a Schleich flask ( π_i) (bis (2-phenylpyridinyl · N, Cr) iridium (III) gas salt dimer) (200 mg, 0.187 mmol, 1 equivalent) and silver trifluoromethanesulfonate Tritium (144 mmol 315064 60 200418865 g, 0.561 mmol, 3.0 equivalents), and the inside of the flask was replaced with nitrogen. After adding 2-ethoxyacetic acid (1 liter's / s = 5) and 2-phenyl D specific bite (163 μl 1 · 1 2 2 mol, 6 · 0 equivalent), under reflux (13 5 ° C) for 3 hours. The resulting yellow-brown suspension was concentrated, and the residue was purified by column chromatography (eluent: dichloroamidine;): end). After the liquid was concentrated on the column, the solution was recrystallized from hexane / dichloromethane to obtain the title compound (V-i) 208 mg as a yellow powder with a yield of 83.4¾. The NMR data of the product were the same as in Example 11. The total yield from Example 1 was 79.9%. When this step was performed in a single tank, the total yield of Example 11 was 85.9% (refer to Example n). It has been shown that the method according to the invention is advantageously carried out in a single tank. Comparative Example 1 Compound (5-6) was produced according to the method described in wo 02/02714 (Patent Document # 1) (see [2- (2,4-difluorophenyl residue intyl_n, c6,] silver文 One, two, and two mills were placed in a foreigner's flask of the social culture; Zumi, 1.42 millimoles, 1 equivalent), a toilet factory, silver dimethymethanesulfonate (1) (1.09 g, 4.26 millimoles, 3 · 0 equivalent), and the plant was red and the inside of the bottle was replaced with nitrogen. Add 2- (2, heart-rat base) Mouth fixed (2 bucket / 〇Λ. Mao Sheng 'S / S == 4) After mixing with water (1 ml, s / s = 2), heat the mixture # 八 物 in a 200 C oil bath and wish to stir for 3 hours. The resulting black mixture was dried to dryness, and the residue? ^^ Jin, Erxi Take g 桎 chromatographic purification (eluent: dichloro hydrazone). After concentrating the column for liquid separation, the outsider 仏 / c tianji 垸 / dichloromethane is recrystallized to obtain the title compound (5-6) 5 71 mg ^ NMP ^, H 4 color powder, yield 52.7%. The NMR data of the product is the same as in Example 12. 315064 61 200418865 According to the method of the present invention, a variety of trivalent six buds can be effectively provided in the traditional manner. Metalized iridium complexes, and these complexes As the material for the element of the excitation light. 62315064
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002328823A JP2004161661A (en) | 2002-11-12 | 2002-11-12 | Method for producing iridium complex |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200418865A true TW200418865A (en) | 2004-10-01 |
| TWI253449B TWI253449B (en) | 2006-04-21 |
Family
ID=32310551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW92130189A TWI253449B (en) | 2002-11-12 | 2003-10-30 | Production of iridium complexes |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2004161661A (en) |
| AU (1) | AU2003276717A1 (en) |
| TW (1) | TWI253449B (en) |
| WO (1) | WO2004043974A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI586674B (en) * | 2012-08-07 | 2017-06-11 | 麥克專利有限公司 | Metal complexes |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1763902B1 (en) * | 2004-07-07 | 2018-08-29 | Universal Display Corporation | Stable and efficient electroluminescent materials |
| US7709100B2 (en) * | 2004-07-07 | 2010-05-04 | Universal Display Corporation | Electroluminescent efficiency |
| US7399857B2 (en) | 2005-03-31 | 2008-07-15 | Eastman Kodak Company | Synthesis of organometallic cyclometallated transition metal complexes |
| EP2036914A1 (en) * | 2005-06-30 | 2009-03-18 | Koninklijke Philips Electronics N.V. | Electro luminescent metal complexes |
| KR100776826B1 (en) * | 2006-06-14 | 2007-11-29 | 고려대학교 산학협력단 | Method of Preparation of Iridium Complexes |
| JP2009084267A (en) * | 2007-08-16 | 2009-04-23 | Ishihara Sangyo Kaisha Ltd | Rare earth complex and luminescent material using the same |
| EP2217608B1 (en) * | 2007-11-21 | 2012-09-05 | Bio-Rad Laboratories, Inc. | Photoluminescent metal complexes for protein staining |
| EP2075251A3 (en) * | 2007-12-31 | 2009-10-21 | Gracel Display Inc. | Novel red electroluminescent compounds and organic electroluminescent device using the same |
| JP4542607B1 (en) | 2009-08-31 | 2010-09-15 | 富士フイルム株式会社 | Method for sublimation purification of iridium complex and method for producing organic electroluminescent device |
| WO2014094962A2 (en) * | 2012-12-21 | 2014-06-26 | Merck Patent Gmbh | Metal complexes |
| JP6556629B2 (en) * | 2012-12-21 | 2019-08-07 | メルク パテント ゲーエムベーハー | Metal complex |
| US20150349277A1 (en) * | 2012-12-21 | 2015-12-03 | Merck Patent Gmbh | Metal complexes |
| CN113201022A (en) * | 2021-04-29 | 2021-08-03 | 南京邮电大学 | Small conjugated phosphorescent metal iridium (III) complex with isomer and preparation method and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5241053B2 (en) * | 2000-08-11 | 2013-07-17 | ザ、トラスティーズ オブ プリンストン ユニバーシティ | Organometallic compounds and radiation-transfer organic electrophosphors |
-
2002
- 2002-11-12 JP JP2002328823A patent/JP2004161661A/en not_active Abandoned
-
2003
- 2003-10-30 TW TW92130189A patent/TWI253449B/en not_active IP Right Cessation
- 2003-11-07 WO PCT/JP2003/014192 patent/WO2004043974A1/en not_active Ceased
- 2003-11-07 AU AU2003276717A patent/AU2003276717A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI586674B (en) * | 2012-08-07 | 2017-06-11 | 麥克專利有限公司 | Metal complexes |
| US11917901B2 (en) | 2012-08-07 | 2024-02-27 | Udc Ireland Limited | Metal complexes |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003276717A1 (en) | 2004-06-03 |
| TWI253449B (en) | 2006-04-21 |
| WO2004043974A1 (en) | 2004-05-27 |
| JP2004161661A (en) | 2004-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7179251B2 (en) | Organic light-emitting materials based on tetradentate platinum ONCN complexes, their synthesis methods and their use in organic light-emitting diodes | |
| TW200418865A (en) | Production of iridium complexes | |
| TWI316540B (en) | Platinum complex and luminescent element | |
| JP5198856B2 (en) | Metal complex | |
| US8030490B2 (en) | Phosphorescent iridium complex with non-conjugated cyclometalated ligands, synthetic method of preparing the same and phosphorescent organic light emitting diode thereof | |
| Yan et al. | Regioselective Syntheses of Imidazo [4, 5-b] Pyrazin-2-Ylidene-Based Chelates and Blue Emissive Iridium (III) Phosphors for Solution-Processed OLEDs | |
| TW200904820A (en) | Blue phosphorescent imidazophenanthridine materials | |
| TW200413497A (en) | Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | |
| JPWO2018084189A1 (en) | Method for producing iridium complex, iridium complex and light emitting material comprising the compound | |
| TW201240988A (en) | Tridentate ligand deriving from 4,4'-dicarboxy-2,2'-bipyridine basic unit, metal complex and applications thereof | |
| KR20160098398A (en) | Raw material and production method for cyclometallized iridium complex | |
| Xu et al. | Synthesis, structure, photophysical and electrochemical properties of series of new fac-triscyclometallated iridium complexes with carbazole or oxadiazole moieties | |
| TW201725211A (en) | Method for producing cyclometalated iridium complex | |
| CN102229568B (en) | Preparation and use for phenyl ether-bridged N-heterocyclic carbene metal complex | |
| US8957208B1 (en) | Heteroleptic iridium complex bearing diazolate chelate | |
| US20230101042A1 (en) | Organic electroluminescent materials and devices | |
| CN107163083B (en) | Tetradentate ring metal platinum (II) and palladium (II) complex phosphorescent material based on triazole structural unit | |
| TWI421329B (en) | Iridium complexes and organic light-emitting diodes comprising the same | |
| CN107383105B (en) | Iridium complex and nitrogen-containing tridentate | |
| WO2013136978A1 (en) | Complex compound having imidazo[1,5-a]pyridine derivative as ligand | |
| JP2004238379A (en) | Method for producing orthometallated iridium complex | |
| Lu et al. | Synthesis, structures, and photophysical properties of orange-red emissive Cu (I) complexes of 9, 9-dimethyl-4, 5-bis (diphenylphosphino)-9H-xanthene (Xantphos) with the substituted N-hetercycle carbene (NHC) ligand | |
| US8394979B2 (en) | Process for preparing cycloplatinated platinum complexes, platinum complexes prepared by this process and the use thereof | |
| TWI585094B (en) | Raw material for cyclometalated iridium complexes and method for producing the same | |
| CN113831371A (en) | [3+2+1] coordination configuration iridium metal red light complex, preparation method thereof and organic electroluminescent device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |